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Abstract 
 
 
The term “theranostics” defines the effort to develop individualized therapies by the combination 
of diagnostic and therapeutic functions in the same agent. Gold-magnetite hybrid nanoparticles 
(H-NPs) are proposed as innovative theranostic nanotools for imaging-guided radiosensitization 
of cancers. H-NPs are designed to exert a dual function: (i) to provide contrast enhancement in 
magnetic resonance imaging (MRI).and (ii) to enhance radiation effects in the cancer. The 
imaging and the radiosensitization potentialities of H-NPs arise from the superparamagnetic 
behaviour of magnetite and the large x-ray extinction coefficient of gold, respectively. Hybrid 
nanoparticles allows cancer theranostics as the biodistibution of nanoparticles can be tracked by 
MR imaging, providing a real-time picture of the cancer radiosensitivity profile and allowing 
precise modulation of radiotherapy.  
The purposes of this work are to synthetize properly designed gold-magnetite hybrid 
nanoparticles and to provide preliminary in vitro evaluations about the potentialities of 
nanoparticles as MRI-contrast agents and radiosensitizers. 
A novel method for the synthesis of hydrophilic and superparamagnetic Tween20-stabilized 
dumbbell-like gold-magnetite hybrid nanoparticles was set up. Morphology and chemical 
composition of nanoparticles were assessed by transmission electron microscopy, x-ray 
diffraction analysis and ion-coupled plasma optical emission spectroscopy. Colloidal stability and 
magnetic properties of nanoparticles were determined by dynamic light scattering and alternating 
field magnetometer. 
The potentialities of H-NPs for MR imaging were studied using a human 4T-MRI scanner. 
Nanoparticles were proven to induce concentration-dependent contrast enhancement in T2*-
weighted MR-images. The biosafety, the cellular uptake and the radiosensitization activity of H-
  
NPs were investigated in human osteosarcoma MG63 cell cultures and murine 3T3 fibroblasts, 
using specific bioassays and laser scanning confocal microscopy. The results evidenced that 
nanoparticles were taken up by cells without inducing any cytotoxic effects, even at high 
nanoparticle concentration. In addition, nanoparticles were proven to induce osteosarcoma-
specific reduction of cell viability in clonogenic cell cultures treated with radiotherapy.  
The experimental results confirmed the potentialities of H-NPs as theranostic tools for MRI-
guided radiosensitization. Further studies are needed to confirm our findings and to identify other 
potential biological targets for MRI-guided radiosensitization.  
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Preface 
 
In this dissertation, a report of my PhD research activity is provided. The activity was 
carried out in the Biotech Lab, part of the Industrial Engineering Department, of the 
University of Trento (Italy), under the supervision of Prof. Claudio Migliaresi and Dr. 
Devid Maniglio. 
The purpose of the work is to deliver a proof-of-concept about the suitability of gold-
magnetite hybrid nanoparticles for MRI-guided radiosensitization. The activity 
involved the synthesis and the characterization of properly designed nanoparticles 
and the evaluation of the in vitro performances of nanoparticles as contrast agent 
and radiosensitizer.  
In the first chapter, a brief of overview of the physico-chemical properties, the 
biological interactions and the main applications in cancer care of nanoparticles is 
reported. The discussion allowed the identification of the most prominent issues for 
the design of medical nanoparticles. In subchapter 2.1, the results of a previous 
work about the role of size and surface chemistry of gold nanoparticles on blood 
protein adsorption is briefly discussed. The details of this study are reported in 
Appendix.  
In the second chapter, the state-of-art of the research about high-Z nanoparticles for 
radiotherapy enhancement is discussed. The physical and biological mechanisms of 
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nanoparticle radiosensitization are reported and the concept of theranostic 
radiosensitization is introduced. 
The rationale and the aims of the research activity are declared in the third chapter, 
together with the outline of the experimental work. 
In Chapter IV, the methods for the synthesis and the characterization of hybrid 
nanoparticles are presented. The results allowed the determination of the synthesis 
procedure for the production of hybrid nanoparticles with morphology and chemical 
composition suitable for our purposes. 
The methods and the results arising from the study of the magnetic properties and 
the imaging potentialities of hybrid nanoparticles are reported in the Chapter V. In 
particular, the experiment performed using the human MRI-scanner is discussed. 
In chapter VI, the biological assays aimed to evaluate the biosafety, the cellular 
uptake and the radiosensitizing activity of nanoparticles are presented. 
General conclusions and final remarks are delivered in chapter VII.  
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Chapter I 
 
General introduction on medical 
nanoparticles 
 
 
1.1. Physico-chemical properties and medical 
potentialities of nanoparticles 
Nanoparticles are particles of any shape with at least two dimensions in the size 
range from 1 to 100 nm1. Humanity has handled nanoparticles for millennia in order 
to obtain manufacts with superior mechanical performances or for artistic purposes. 
For instance, ancient Romans used to synthetize colloidal gold for glass staining 
because of its characteristic coloration2. The technological progress occurred in the 
last two centuries has allowed a detailed study of nanoparticles, revealing very 
peculiar physico-chemical properties and promoting the diffusion of nanoparticles in 
several applications ranging from electronics, optics, environmental technologies to 
medicine. 
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The physics of nanoparticles is significantly different from the physics of bulk 
materials as, at the nanoscale, size and geometry can affect the atomic processes 
responsible for the physical behaviour of materials. Therefore, unlike larger 
materials, nanoparticles exhibit a variety of size-dependent and shape-dependent 
properties. The fluorescent behaviour of quantum dots is a typical example of size-
dependent properties of nanoparticles. Quantum dots are semiconductive 
nanoparticles that experience the so-called quantum confinement effect. This 
phenomenon arises from the nanometric confinement of electrons, which behave 
like in quantum well conditions breaking the valence and conductive bands and 
leading to the formation of quantized energy levels. The energy differences among 
the quantized levels are determined by the nanoparticle size in such way that 
properly designed semiconductive nanoparticles (quantum dots) can be used as 
fluorescent probes with size-tunable excitation and emission wavelength3.  
Size is fundamental also in the case of superparamagnetic nanoparticles. 
Superparamagnetism is a form of magnetism that occurs in ferromagnetic and 
ferrimagnetic materials under certain conditions. In particular, if the size of particles 
is sufficiently small, the magnetization can randomly flip direction under the influence 
of temperature. If an external magnetic field is applied, the magnetic momentum of 
nanoparticles are oriented in the direction of the field, however no residual 
magnetization is maintained when the external field is removed, as result of the 
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thermal flipping. Therefore, superparamagnetic nanoparticles can be magnetized 
like a paramagnet, although their magnetic susceptivity is comparable to that of 
ferromagnetic materials4.  
Shape is another parameter that could strongly affect the physical behaviour of 
nanomaterials. In particular, the optical properties of metal nanoparticles are well-
known to be shape-dependent. Passing from bulk to nanometric materials, surface 
plasmon resonance (SPR) becomes the main mechanism responsible for the optical 
response of metals as bulk scattering is negligible for particles smaller than 50 nm. 
Surface plasmon resonance is due to the collective oscillations of free electrons, 
stimulated by electromagnetic waves with frequency in the resonance band of 
electron oscillations. The SPR band depends on the shape of nanoparticles as the 
oscillation modes of electrons may change changing the nanoparticle symmetry5. 
The shape-dependence of the SPR band is particularly interesting in the case of 
noble metal nanoparticles. In particular, the shape of gold nanoparticles can be 
tuned in order to obtain SPR absorption in a wide spectral interval ranging from the 
visible to the near-IR. For example, spherical gold nanoparticles exhibit SPR 
absorption in the green part of the visible spectrum, while the SPR band of rod-like 
nanoparticles is red-shifted. In Fig. 1, a pictorial representation of quantum effect, 
superparamagnetism and surface plasmon resonance is reported. 
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Figure 1.  In the superparamagnetism box, FM, PM and SPM stand for ferromagnetic, 
paramagnetic and superparamagnetic materials, respectively. 
Besides physics, nanoparticles differ from micrometric and millimetric material also 
for larger chemical reactivity. In fact, considering a typical atom size is about 1 Ǻ, 
nanoparticles can be assumed as clusters of small number of atoms with a high 
percentage of surface atoms with unsaturated atomic orbitals. Although the large 
chemical reactivity of nanoparticles can result particularly useful for catalytic 
applications, the excess of surface energy makes nanoparticles thermodynamically 
unstable. Indeed, if the surface is not protected with stabilizing molecules, called 
capping agents, interactions between nanoparticles could occur in order to reduce 
the surface energy and this generally results in particle aggregation6. 
Recently, the opportunity to use nanoparticles for medical applications is object of 
intense scientific interest. In fact, nanoparticles provide the possibility to interact with 
the biological environment at the same size scale of the proteins, the smallest 
building blocks of the biological matter. Therefore, thanks to their biological mobility, 
 24 
nanoparticles can reach biological targets impossible to achieve otherwise and their 
phyisico-chemical properties offer diagnostic and therapeutic opportunities that 
molecular drugs cannot provide. In particular, the size-dependent and the shape-
dependent properties of nanoparticles can be finely tuned in order to exert specific 
medical functions. For examples, nanoparticles can be used as drug carriers, optical 
and magnetic absorbers for tissue ablation, imaging probes, contrast agents or 
magnetic nanoactuators7,8. In addition, the high surface-to-volume ratio of 
nanoparticles allows the conjugation of nanoparticles with specific molecules for 
better biological targeting and additional functionalities.   
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1.2. Biological interactions and toxicity concerns of 
medical nanoparticles 
 
Nanoparticles for medical applications should be properly designed in order to 
promote favourable interactions with the biological environment where they are 
expected to operate. In particular, medical nanoparticles must be able to reach the 
biological targets in such a way to effectively deliver the treatment they are designed 
for, limiting the insurgence of adverse events. Following administration, 
nanoparticles interact first with the proteins in blood or in other extracellular fluids 
and, secondly, with cells in the tissues where they have been accumulated. 
Chemical composition, size and surface chemistry can strongly influence the way 
nanoparticles interact with proteins, cells and tissues determing nanoparticle toxicity 
and influencing the efficacy of the treatment. Therefore, the design of safe and 
effective medical nanoparticles requires a basic knowledge about the role of the size 
and the surface chemistry in the determination of the biological fate of nanoparticles. 
Considering that this work is aimed to develop medical gold-magnetite 
nanoparticles, the following discussion is mainly focused on gold and iron oxide 
nanoparticles. 
Once in the bloodstream, nanoparticles interact with blood proteins and 
biomolecules generating a biological interface on the surface, called ‘‘corona’’. The 
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formation of such protein corona is a dynamic process. In general, for macroscopic 
materials, the surface is immediately covered by the most abundant blood proteins, 
which, in a second time, may be replaced by proteins with higher surface affinity. 
Previous works demonstrated the occurrence of exchange mechanisms also for 
metal nanoparticles9. The composition of the protein shell at equilibrium contributes 
to define the fate of nanoparticles and the occurrence of possible side effects. These 
could involve clearance of nanoparticles from the bloodstream, activation of 
complement cascade or thrombus formation10. Until now, very few studies have 
been carried out in order to obtain a complete comprehension about the occurrence 
of side effects due to the formation of unfavourable protein corona. In this contest, 
medical nanoparticles are generally designed to avoid as much as possible the 
amount of adsorbed proteins. The conjugation of nanoparticles with antifouling 
molecules could be a strategy to limit blood proteins adsorption. In particular, 
negative-charged long-chain molecules have been identified as a candidate for this 
purpose, as shown by a work of our research group11. The study was aimed to study 
the role of size and surface chemistry of gold nanoparticles on the process of blood 
protein adsorption. The details of the work are reported in Appendix. The 
experimental findings supported the belief that negative-charged nanoparticles, 
coated with the long-chain molecules, should behave better than other coatings in 
limiting the adsorption of blood proteins on the nanoparticle surface. 
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The interaction among nanoparticles and cells is another fundamental issue that 
should be considered in the design of medical nanoparticles. Due to the size 
difference, the nanoparticle-cell interactions often results in the cellular uptake of 
nanoparticles. Although some evidences highlighted that ultrasmall nanoparticles (< 
10 nm) can enter into the cells by diffusion through the cell membrane, endocytosis 
has been identified as the principal mechanism for cellular uptake of nanoparticles12. 
Endocytosis involves the enclosure of the substances to be internalized by the cell 
membrane forming vesicles, which are furtherly released into the cytoplasm. Once in 
the cytoplasm, nanoparticle-loaded vesicles generally reach endomes and, in a later 
stage, lysosomes, where nanoparticles are degraded or excreted from the cell. 
Although Tkachenko et al. demonstrated the possibility to functionalize gold 
nanoparticles with specific peptides allowing nuclear targeting, nanoparticles 
generally cannot enter into the nucleous13. Endocytosis offers three main routes for 
nanoparticle internalization in cells: phagocytosis, macro-pinocytosis and receptor-
mediated endocytosis14. Phagocytosis is a ligand-induced process, part of the 
immune system of animals, and is restricted to specialized cells, including 
macrophages, monocytes and neutrophils. Phagocytic cells can internalize cell 
debris, apoptotic cells and foreign bodies with diameter between 0.5 µm and 10 
μm15. In non-phagocytic cells, nanoparticles can be internalized mainly by macro-
pinocytosis, a nonspecific mechanism by which the compounds dispersed in the 
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fluid are taken up at the same concentration as in the surrounding medium. In 
addition, receptor-mediated endocytosis (RME), based on the activation of clathrin 
and claveolin pathways triggered by the binding of specific ligands, can occur. In 
Fig. 2, mechanisms of nanoparticle internalization by cells are summarized. 
 
 
Figure 2. From left to right: particle uptake by phagocytosis, liquid internalization with 
included nanoparticles by macro-pinocytosis, specific binding of ligands to cell surface 
receptors and subsequent receptor-mediated endocytosis (RME). 
 
The size of the vesicles formed by macro-pinocytosis and RME are limited and 
nanoparticles larger than 200 nm are typically unable to enter in non-phagocytic 
cells16. Moreover, nanoparticles in the size range from 40 nm to 50 nm were proven 
to be more efficient in cell internalization than smaller and larger nanoparticles17. 
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Beside the size and the presence of specific ligands on the surface, other 
parameters of nanoparticles can affect the uptake process. In particular, increased 
charge, either positive and negative, favors the uptake in both phagocytic and non-
phagocytic cells, and positively charged nanoparticles are taken up more extensively 
than negative ones, because of the negative potential of cell membrane18,19. 
Although the internalization of nanoparticles in cells is needed for several medical 
applications, nanoparticle uptake can lead to unwanted cytotoxicity. In fact, 
nanoparticles can affect the normal biological processes of cells by releasing 
degradation products into the cytoplasm or by generating reactive oxygen species. A 
great mole of studies has been conducted in the last years to determine the 
cytotoxicity effects of gold and iron oxide nanoparticles considering different cell 
types, nanoparticle size and surface chemistry, incubation time and concentrations. 
The studies were mainly based on the evaluation of cell integrity following incubation 
with nanoparticles in vitro. A review conducted by Lewinski et al showed that, in 
general, cells can survive to short-term exposure to gold and iron oxide 
nanoparticles at concentrations lower than 200 ug∙mL-120. For higher concentrations, 
the occurrence of toxic effects strongly depends on certain nanoparticle parameters. 
In particular, positive charged nanoparticles resulted more cytotoxic than negative 
charged nanoparticles, probably because of the higher cellular uptake, with sligh 
dependency on the size21. Furthermore, the chemistry of surface coatings can 
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determine the occurrence of cytotoxic effects for the presence of specific chemical 
groups or for the lipophilic behaviour of certain capping agents. 
Beside opsonisation and cytotoxicity, the pharmacokinetics and the biodistribution of 
nanoparticles represent another critical issue for the employment of nanoparticles in 
clinics. In fact, nanoparticles usually reveal faster clearance from the bloodstream 
compared to standard hydrophilic drugs and the biodistribution of nanoparticles can 
vary depending on the nanoparticle size. Several studies have investigated the 
biodistribution of gold nanoparticles intravenous-injected in rats examining different 
nanoparticle size and surface chemistry. The results highlighted that nanoparticles 
are quickly removed by the circulating system by the reticuloendothelian system 
(RES). The high efficiency of RES in nanoparticle clearance is probably due to the 
opsonisation of nanoparticles by blood proteins. In fact, nanoparticles capped with 
antifouling molecules, like PEG, exhibit longer circulating time compared to those 
with less stealth capacities22. Size is crucial in determining the accumulation profile 
of nanoparticles. In fact, as reported by Hirn et al, small nanoparticles, less than 6 
nm, follow a different clearance routes than larger nanoparticles. In particular, small 
nanoparticles have longer retention time in blood tissue compared to larger 
nanoparticles and they are cleared mainly by kidney resulting in urine excretion. On 
the contrary, 24h clearance of larger nanoparticles occurs principally in liver and 
spleen leading to excretion by faeces. The circulating time of larger nanoparticles 
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scales with the inverse of size. Furthermore, small nanoparticles can be easily reach 
organs like brain, lungs and heart23. Considering that gold nanoparticles are often 
designed for cancer care applications, the role of size has been investigated in 
terms of tumour accumulation. Perrault et al. studied the cancer uptake of PEG-
coated nanoparticles with different size in tumour bearing mice revealing that 60 nm 
represents the optimal size to maximize PEG-coated nanoparticle accumulation in 
cancer, probably as result of long circulating time and preferential cellular 
internalization24. Furthermore, Fraga et al. studied the short-term (28 days) toxicity 
of gold nanoparticles reporting that no significant change in food and water intake 
and variation in organ indexes was detected following nanoparticle administration25. 
Although systematic studies about the pharmacokinetics and the biodistribution of 
iron oxide nanoparticles are fewer than those about gold nanoparticles, iron oxide 
nanoparticles have been recognized to behave similarly to gold nanoparticles in 
terms of circulating time and tissue accumulation confirming that size and surface 
chemistry are the principal parameters determining nanoparticle clearance and 
biodistribution. In particular, nanoparticles larger than 10 nm are quickly cleared 
from the bloodstream within 24 h and the clearance mainly occurs in liver and 
spleen26,27. Moreover, no toxicity was detected in mice injected with iron oxide 
nanoparticles at the concentrations typically used in vivo (~ 1 mg/kg)28. 
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1.3. Cancer diagnostics, therapeutics and 
theranostics based on nanoparticles 
 
Cancer care represents the most promising application field for medical 
nanoparticles. In the last decades, nanoparticles have been studied and developed 
primary for use in drug delivery systems (e.g. liposomes, gelatin nanoparticles, 
micelles) and, more recently, for therapeutic and diagnostic treatments exploiting the 
peculiar physico-chemical properties of metallic, semimetallic and carbon 
nanoparticles. 
The suitability of nanoparticles for oncologic applications is supported by the 
evidence that macromolecules dispersed in the bloodstream are much more 
selective than low-molecular-weight molecules in targeting solid cancers. Selective 
accumulation of macromolecules in tumours is due to the enhanced permeability 
and retention of cancers (EPR effect) and arises from the higher density of blood 
vessels with defective architecture in tumours compare to normal tissue. The hyper-
vascularization of cancers ensures a sufficient supply of nutrients and oxygen for a 
rapid growth and occurs at the first stages of tumour formation. In fact, when 
malignant cell aggregates reach the size of 0.8-1 mm, new vasculature starts to be 
generated as result of the extensive production of vasculature endothelial grow 
factors (VEGF) and other permeability factors. Cancer angiogenesis leads to the 
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formation of blood vessels with an abnormal structure, including large endothelial 
cell gap junctions ranging from 200 nm to 1.5 um, irregular vascular alignment, lack 
of smooth muscle layer and other defects. Although the high density of blood 
vessels induces an increase of fluid pressure in tumours, the architectural features 
of cancer vasculature allow the extravasation of macromolecules within the tumours. 
Furthermore, cancer tissues experience a lack a lymphatic drainage leading to 
longer retention of the compounds accumulated in the cancer compared to normal 
tissues29,30. In Fig. 3, a schematic description of EPR effect is reported. 
Since the discovery of EPR effect in 1986, several strategies based on passive 
targeting have been developed. The first attempts involved the conjugation of 
standard low-molecular-weight chemotherapy drugs with high-molecular-weight 
molecules, like polymers or serum macromolecules. Furtherly, nanoparticles have 
been studied as novel carriers for hydrophobic anticancer drugs (e.g. doxorubicin), 
able to increase cancer selectivity reducing side effects. In fact, nanoparticles reveal 
superior stealth properties than other drug delivery systems limiting the unspecific 
drug uptake by RES31. Moreover, nanoparticles can perform active targeting of 
cancers by the conjugation with molecules able to bind tumour-specific ligands and 
several groups have reported the use of antibody-conjugated nanoparticles to 
localize cell surface proteins32–34. A lot of different nanoparticle formulations have 
been tested for anticancer drug delivery ranging from lipid-based liposomes, 
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micelles and polymersomes to protein-based, polymeric and mesoporous silica 
nanoparticles35. 
 
 
Figure 3. Macromolecules and nanoparticles dispersed in the bloodstream are selectively 
accumulated in the cancer tissue as result of large endothelial cell junction gaps and 
absence of smooth muscle layer in cancer vasculature. In addition, cancer tissue 
experiences lack of lymphatic drainage leading to longer retention of macromolecules and 
nanoparticles compared to normal tissues. 
Metallic, semimetallic and carbon nanoparticles offer the opportunities to perform 
alternative cancer diagnostics and therapy thanks to their physico-chemical 
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properties. For instance, quantum dots have been developed for cancer applications 
in order to provide fluorescence imaging of subcutaneous cancers and carbon 
nanoparticles (e.g. fullerenes and carbon nanotubes) have been investigated for 
drug deliver, optical imaging and phototherapy. However, gold and iron oxide 
nanoparticles represent the most studied types of hard-matter nanoparticles for 
cancer care thanks to their unique features. 
Gold nanoparticles were approved for the care of rheumatoid arthritis several 
decades ago and recently they have been studied as nanoplatforms for 
phototherapy, photoacoustic imaging, CT imaging and radiotherapy enhancement in 
cancers. The versatility of gold nanoparticles arises from the well-known 
biocompatibility of gold and the facile gold chemistry. In particular, the morphology of 
gold nanoparticles can be easily tuned in order to shift the surface plasmon 
resonance band in the near-IR range, where the optical absorption of biological 
tissues is minimal. Gold nanoparticles have been studied for phototherapy as the 
large optical absorption of gold nanoparticles can be used for cancer ablation or 
sensitization to further treatments36,37. Similarly, photo-acoustic tomography exploits 
the local pressure variations induced by the fast temperature increase following 
nanoparticle light absorption. In fact, if the exciting light is delivered by an ultrasound 
frequency pulsed laser, fast variations of pressure are generated inducing acoustic 
waves in the tissues. These waves can be detected from the skin and cancer 
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imaging is obtained by the reconstruction of the acoustic signals38. The limited 
penetration depth of visible and near-IR light restricts the suitability of phototherapy 
and photo-acoustic tomography to subcutaneous cancers. For deeper tumours, gold 
nanoparticles have been studied as CT contrast agents and radiosensitizers. In fact, 
thanks to the high extinction coefficient of high-Z materials for kilovoltage radiations, 
gold nanoparticles are much more efficient than the biological matter in X-ray 
absorption. The details about the interaction between gold nanoparticles and 
ionizing radiations are discussed in the next chapter. 
Superparamagetic iron oxide nanoparticles have been widely investigated since the 
1980s for magnetic-targeted drug delivery, MRI contrast enhancement and 
hyperthermia. Iron oxide nanoparticles are highly biocompatible and several groups 
reported the synthesis of liposomes or polymeric particles loaded with 
superparamagnetic nanoparticles for drug delivery in subcutaneous cancers by 
magnetic targeting using a permanent magnet in proximity of the tumour 31,39. In vivo 
studies revealed magnetic carriers can improve drug delivery in cancer in terms of 
selectivity and cancer regression40–43. 
Superparamagnetic nanoparticles have been also used as contrast agents in 
magnetic resonance imaging (MRI). Magnetic resonance imaging provides 
anatomical images of the body exploiting the magnetic relaxation processes of 
protons in H1 nuclei of the water molecules. The patient is placed in a strong static 
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magnetic field and the magnetic moments of H1 protons aligned to the static field are 
flipped on the transverse plane using radiofrequency pulse at the Larmor precession 
frequency of protons. When the radiofrequency pulse is turned off, magnetic 
moments of flipped protons undergo to longitudinal relaxation (T1) and transverse 
relaxation (T2). The first involves the recovery of magnetization in the direction of 
static magnetic field. The second occur on the transverse plane and arises from the 
loss of phase coherence in the precession of protons due to their magnetic 
interactions with each other and with other fluctuating moments in the tissue. As 
dephasing can also be affected by local inhomogeneities in the applied longitudinal 
field, superparamagnetic nanoparticles can be used as negative contrast agents in 
T2-weighted MRI. In fact, the magnetization of superparamagnetic nanoparticles in 
the tissue can locally disturb the static magnetic field leading to a decrease of 
transverse relaxation time. Iron oxide nanoparticles have been used as 
superparamagnetic contrast agents instead of standard contrast agents based on 
gadolinium because of the superior biocompatibility of iron oxide. Commercial 
agents based on superparamagnetic nanoparticles are currently available, such as 
‘Feridex I. V’, an iron oxide contrast agent marketed by Advanced Magnetics Inc. 
Properly designed superparamagnetic iron oxide nanoparticles have been studied 
for cancer imaging. For instance, polymer-coated nanoparticles functionalized with 
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targeting molecules have demonstrated to provide excellent contrast enhancement 
of cancer tissue in vivo experiment44–46. 
Furthermore, superparamagnetic iron oxide nanoparticles can be used for cancer 
hyperthermia. In fact, if nanoparticles are placed in an AC magnetic field, the 
processes occurring in magnetic moment reversal (mainly Brownian rotation and 
Néel relaxation) induce the generation of heat, which is transferred to the 
surrounding environment. Nanoparticles-based hyperthermia can be used for cancer 
therapy by infiltrating the tumours with superparamagnetic iron oxide nanoparticles 
and irradiating the cancer lesion with AC magnetic field at the proper frequency47–49. 
This approach has been demonstrated to provide significant benefits in terms of 
cancer regression and sensitization and MagForce GmbH, in Munich, currently 
deliver nanoparticle-based hyperthermia in oncologic patients by in situ injection of 
superparamagnetic iron oxide nanoparticles. 
The versatility of nanoparticles allows the development of multifunctional 
nanoparticles able to combine imaging and therapeutic potentialities. Such 
nanoparticles provide the opportunity to test the patient response allowing the 
modulation of the treatment on the individual patient. People generally referred to 
medical treatments based on drugs or agents able to integrate therapeutic and 
prognostic purposes using the term “theranostics”. Currently, theranostic treatments 
are object of intense scientific interest as the opportunity to module the therapy on 
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the needs of the individual patient represents the main target of personalized 
medicine, which is generally considered the next frontier of modern medicine50. In 
our group, theranostic iron oxide nanoparticles, functionalized with antibodies 
specific for endothelial grow factors receptor (EGFr), have been developed for real-
time MRI-tracking of doxorubicin-loaded nanoparticle biodistribution in mice 
engrafted with human colorectal cancers. Other groups reported similar studies and 
the results support the feasibility of the cancer theranostics using 
superparamagnetic iron oxide nanoparticles for MRI-monitored drug delivery51. In 
addition, iron oxide, gold and gadolinium nanoparticles as well offered theranostic 
opportunities. In particular, iron oxide nanoparticles can be used for MRI contrast 
enhancement and hyperthermia, while gold and gadolinium nanoparticles have been 
studied for CT-guided and MRI-guided radiosensitization, respectively52–54. 
Furthermore, the development of hybrid nanoparticles has enlarged the possibilities 
offered by nanoparticles for cancer theranostics. For instance, Kirui et al reported a 
study regarding gold-iron oxide hybrid nanoparticles for MRI-guided phototherapy on 
tumor bearing mice55 and Kim et al investigated the opportunities for MRI, 
fluorescence imaging and drug delivery of iron oxide nanoparticles coated by a shell 
of mesoporous silica58. Considering the increasing demand of personalized 
medicine and the potentialities of hybrid nanoparticles combined imaging and 
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therapy of cancers, more and more medical strategies based on theranostic hybrid 
nanoplatforms are expected to emerge in the next years.  
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Chapter II 
 
 
Nanoparticles for advanced radiotherapy 
 
 
2.1. Basic concepts about radiotherapy 
Radiotherapy is the second most diffused treatment for cancers after surgery and 
more than half of oncologic patients are estimated to experience radiotherapy during 
their clinical management57,58. In particular, radiotherapy is the elected treatment for 
long-term control of head, neck, lung, cervix, bladder, prostate and skin cancers. 
Radiotherapy employs ionizing photon radiations, delivered in the cancer site, in 
order to induce lethal damages in tumour cells. Radiation-induced cytotoxicity 
results from a succession of physical, chemical and biological processes. As first, 
incident photons interact with orbital electrons mainly by photoelectric effect and 
Compton scattering effect, resulting in the occurrence of ionization and excitation 
events. If sufficiently energetic, secondary electrons, ejected by ionization, interact 
with other orbital electrons giving rise to ionization/excitation cascades. The density 
of ionization/excitation events depends on the radiation dose deposited in the 
tissues, defined as the amount of energy released by radiations in a unit of mass. 
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Radiation dose is measured in Grays (Gy) and 1 Gy corresponds to 1 Joule per Kg 
of matter. The processes of ionization and excitation of molecules lead to the 
breakage of chemical bonds and formation of free radicals that rapidly react with the 
surrounding matter. Such chemical reactions result in the fixation of radiation 
damages leading to stable changes in biological molecules. For clinical radiation 
doses, the most part of radiation-induced lesions occurred in non-fundamental 
biomolecules which are easily replaced without relevant effects on cell behaviour. 
However, some lesions can occur in the DNA molecules, as consequence of direct 
damages due to ionization/excitation processes or indirect damages provoked by 
the interaction with free radicals. The vast majority of DNA lesions are successfully 
repaired by specific enzymatic reactions, however it could happen that some of them 
fail to repair. Such irreversible modifications could have severe effects in terms of 
cell viability and proliferation. In particular, DNA damages could induce cell death by 
apoptosis, necrosis and mitotic catastrophe or could induce replicative senescence 
depending on the cell type. As consequence of radiation-induced cell death, tumour 
regression occurs after irradiation, often followed by regrowth. If regrowth fails to 
occur during the lifespan of the patient, the cure of cancer, even called local control, 
is achieved. Due to the difficulty to confine the irradiation on the cancer site, also 
healthy tissues can be irradiated during radiotherapy. Healthy tissue irradiation could 
induce short-term and long-term side effects. In particular, the killing of stem cells 
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causes the early manifestations of normal tissue damage during the first weeks and 
months after irradiation. Examples are the breakdown of the skin or the mucosa, the 
denudation of the intestine and the hematopoietic damage. Furthermore, long-term 
effects include the appearance of second tumours induced by radiations, even after 
years from the irradiation59,60. Clinical practice guidelines define the dose level for 
the cancer local control and the insurgence of adverse events in the healthy tissues. 
 
Radiotherapy equipment is usually composed by an electron linear accelerator with 
a tungsten alloy target at the end of the accelerating path. The collision among the 
pre-accelerated electrons and the tungsten target results in the generation of 
photons, via bremsstrahlung effect. The spectrum of the emitted photons follows a 
broad energy distribution, whose highest energy value corresponds to the 
acceleration energy of electrons. This value is called peak energy and is generally 
indicated in peak kilovolts (kVp) or peak megavolts (MVp). Radiotherapy systems 
allow the modulation of peak energy value by setting the electric potential across the 
linear accelerator. In the clinical practice, peak energy should be carefully tuned for 
optimal dose shaping as higher peak energy values correspond to higher 
penetration depth of the emitted photons in biological tissues. For instance, skin 
treatments generally imply peak energy values in the range from 100 kVp to 500 
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kVp, while peak energies between 1 MVp and 15 MVp are typically used in the 
treatment of deeper tissues.  
The geometry of the photon beams is carefully tuned in order to optimize the dose 
deposition in the cancer preventing as much as possible healthy tissue irradiation. 
For this purpose, anatomical pictures offered by computer tomography (CT), 
positron emission tomography (PET) and MR imaging are used to plan radiation 
treatment. Several systems have been developed to improve the outcomes of 
radiotherapy. For instance, multiport irradiation method, based on multiple radiation 
beams delivered from different directions, has been implemented to provide better 
dose shaping. In addition, dose fractionation over a week or more is widely used to 
enhance cancer cell toxicity as normal cells generally recover faster than cancer 
cells. 
However, radiotherapy of radioresistant cancers still remains challenging. For 
example, the local control of hypoxic tumours requires the deposition of larger 
radiation dose compared to normally-oxygenated tissues. In fact, hypoxia, due to the 
lack of blood supply in tumour tissue, induces cancer radioresistance as oxygen 
radicals are the most efficient chemical species for the fixation of radiation damages. 
To enhance cancer cell killing while minimally affecting healthy tissues, several 
pharmacological adjuvants for radiotherapy have been tested since the 1960s. A 
typical strategy for cancer radiosensitization involves the combination of 
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chemotherapy drugs (e.g. cisplatin, 5-fluororacil and mitomycin C) and radiotherapy 
in order to inhibit the DNA repair mechanisms following irradiation. Furthermore, a 
variety of radiosensitizing drugs have been designed to be activated by radiations 
and to target specific characteristics of tumours, like hypoxia. The majority of the 
hypoxia-specific radiosensitizers belongs to the family of nitroimidazoles that 
selectively target hypoxic cells and mimic the effect of oxygen in the fixation of DNA 
damages. However, selectivity still remains the main limitation for clinical 
implementation of radiosensitizers61,62. In this contest, innovative tools for 
radioresistant cancer sensitization are strongly demanded.  
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2.2. High-Z nanoparticles for radiotherapy 
enhancement 
In the recent years, nanoparticles composed by high atomic number materials (high-
Z nanoparticles) have been proposed as alternative platforms for selective cancer 
radiosensitization. As discussed in Chapter I, properly designed nanoparticles can 
target cancer tissue exploiting the architectural defects of tumour vasculature. In 
particular, the enhanced permeability and retention effect (EPR) occurring in cancer 
tissues allows passive targeting of cancers. Normal tissues are usually impermeable 
to nanoparticle infiltration and nanoparticles are quickly cleared from the 
bloodstream by filtering organs. Therefore, nanoparticles can provide higher cancer 
selectivity than standard low-molecular-weight drugs with minimal long-term 
accumulation in the healthy tissues. 
Currently, high-Z nanoparticles have been studied to enhance the deposition of 
radiation dose in cancer tissue combining the targeting properties of nanoparticles 
and the large x-ray absorption of heavy materials. In fact, high-Z materials present 
higher extinction coefficient compared to the biological matter for photons in the 
kilovoltage energy range, as shown in Fig. 4. 
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Figure 4 Comparison among the absorption coefficient of gold and soft tissue for photons in 
the energy range from 10 keV to 15 MeV63. 
The interaction among x-rays and heavy atoms results in the generation of low-
energy secondary electrons by Auger effect and photoelectric effect. Secondary 
electrons release all their energy at sub-micrometer distance inducing the formation 
of free radicals at short range. Therefore, kilovoltage irradiation leads to the 
formation of free radicals at high density around high-Z nanoparticles, as confirmed 
by Monte Carlo studies64,65 The local inhomogeneities in radiation dose deposition 
induced by nanoparticles could enhance cell killing probability. In fact, although 
nanoparticles are not incorporated within cell nuclei, the local dose inhomogeneities 
can disrupt lethal cytoplasmic targets (e.g. mitochondria), as shown in Fig. 5. In case 
of megavoltage photon irradiation, the extinction coefficient of high-Z materials and 
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the biological matter are quite similar. Although this evidence might suggest lack of 
radiosensitizing potentialities, computational studies demonstrated high-Z 
nanoparticles provide radiotherapy enhancement even in megavoltage energy 
range66. In fact, the interaction of primary megavoltage radiations with the matter 
results in the formation of secondary photons at lower energy, as consequence of 
Compton scattering. Secondary photons can interact with high-Z nanoparticles 
inducing local dose inhomogeneities, similarly to the case of kilovoltage 
radiotherapy. Therefore, high-Z nanoparticles are reliable platforms for the 
enhancement of both kilovoltage and megavoltage radiotherapy. 
 
Figure 5 High-Z nanoparticles enhance radiation toxicity in cells by inducing sub-micrometer 
inhomogeneities in radiation dose deposition. In particular, nanoparticles release a huge 
amount of secondary electrons in the surroundings. This leads to a dramatic increase of the 
oxidative stress at short-range that may damage lethal cytoplasmic targets, like 
mitochondria. 
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Gold nanoparticles have been widely studied for radiosensitization due to their 
biocompatibility and facile chemistry. In 2004, the pioneering work of Hanfield et al 
reported the in vivo use of gold nanoparticles for cancer sensitization to 
radiotherapy67. Mice bearing subcutaneous EMT-6 mammary carcinoma received a 
single intravenous injection of 1.9 nm diameter gold nanoparticles and they were 
then irradiated by 250 kVp x-rays. One-year survival was 86% versus 20% with x-
rays alone and 0% with gold alone. More recent in vitro and in vivo studies 
confirmed the ability of gold nanoparticles to increase cell killing and tumour 
regression in megavoltage radiotherapy68,69. In particular, the studies highlighted the 
sensitization offered by gold nanoparticles is cell-specific with comparable effects at 
kilovoltage and megavoltage energies, and gold nanoparticles do not enhance DNA 
double-strand breaks as expected from nanoparticles segregated in cytoplasmic 
compartments. The size of gold nanoparticles can also play a fundamental role in 
the determination of the radiosensitization effects. Zhang et al reported a 
comparative study aimed to determine the most suitable size of gold nanoparticles 
for radiosensitization. Among nanoparticles of 4.6, 12.1, 27.3 and 46.6 nm diameter, 
12.1 and 27.3 nm nanoparticles resulted the most efficient in reducing cell surviving 
fraction in vitro and in limiting tumour expansion in mice70. 
In the last years, other types of high-Z nanoparticles have been proposed for 
nanoparticle-mediated radiosensitization. In particular, gadolinium nanoparticles 
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have been investigated for radiotherapy enhancement as gadolinium has significant 
higher absorption coefficient than soft tissues for kilovoltage x-rays and provide MR 
imaging contrast. The combination of imaging properties and high atomic number 
suggested the use of gadolinium nanoparticles for the implementation of imaging-
guided radiosensitization, as discussed in the following section.  
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2.3. Theranostic nanoparticles for imaging-guided 
radiosensitization 
Precise modulation of drug-enhanced radiotherapy requires the accurate 
determination of radiosensitizer distribution in the cancer. In fact, local changes 
could occur in the accumulation of radiosensitizing drugs in cancer tissue leading to 
heterogeneous levels of sensitization across the tumour. The lack of non-invasive 
imaging techniques for the estimation of drug biodistribution is therefore a severe 
limitation for the standardization of conventional radiosensitizers. 
Attempts to develop molecular drugs for combining real-time imaging and 
radiotherapy enhancement has included the development of radioactive iodine-
based molecules able to target specific types of cancer (e.g. prostate)71. However, 
the unsafety of radioactive compounds and the difficulty to translate drug cancer 
selectivity in other types of tumours hinder the clinical diffusion of molecular drugs 
for theranostic radiosensitization. 
In this contest, nanoparticles have been identified as promising theranostic tools for 
imaging-guided radiotherapy. In fact, thanks to their versatility, multifunctional 
nanoparticles can be developed for cancer targeting, real-time imaging and cell 
sensitization to radiations. Iron oxide nanoparticles have been studied as platforms 
able to integrate imaging and radiosensitization. In fact, iron oxide nanoparticles are 
MRI-contrasted and nanoparticle biodistribution can be tracked in real-time after 
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administration. In addition, iron oxide nanoparticles can be loaded with 
radiosensitizing drugs (e.g. cisplatinium) for cancer radiosensitization72,73. 
More recently, gadolinium nanoparticles have been tested in vivo for imaging-guided 
radiosensitization. In 2011, Le Duc et al investigated the opportunity to use 
gadolinium oxide core and polysiloxane shell nanoparticles for MR imaging and 
radiotherapy enhancement in brain-tumour bearing mice74. Contrast enhancement in 
T1-weighted MR images provided an accurate picture of the nanoparticle distribution 
in the cancer allowing the determination of the optimal timing for treatment delivery 
in order to maximize the radiosensitization effect offered by nanoparticles. The 
survival time of mice treated with gadolinium nanoparticles and radiotherapy was 
statistically longer compared to mice treated with radiotherapy only. A further work of 
Dufort et al investigated the theranostic potentialities of ultrasmall nanoparticles 
composed by a polysiloxane matrix filled with gadolinium chelates75. Nanoparticles 
were administrated via inhalation in mice bearing intrapulmonary-inoculated lung 
cancers. After administration, ultrashort echo-time MRI sequences and 
bioluminescence assays confirmed selective nanoparticle accumulation in cancer 
cells. Synergic effect of nanoparticles and radiotherapy was detected in terms of 
survival time increase in mice. 
Gold nanoparticles have been proposed for imaging-guided radiosensitization. In 
2013, Joh et al reported a study regarding PEG-coated injected in sarcoma-
 53 
implanted mice for CT tumour shaping and radiosensitization53. Gold nanoparticles 
provided excellent CT contrast allowing the precise definition of tumour volume. In 
addition, the administration of nanoparticles in combination with radiotherapy 
allowed larger regression of tumour volume compared to radiotherapy or 
nanoparticles only. Mice treated by nanoparticles and radiations survived much 
longer than those treat only by radiotherapy. 
Considering the heterogeneity of experimental conditions among the works reported 
above (e.g. tumour type, radiation dose and energy, nanoparticle administration 
mode) and the absence of comparative studies in literature, it is extremely difficult to 
compare the theranostic performances of different types of nanoparticles and to 
draw reliable conclusions. In particular, universally accepted parameters to quantify 
the overall efficacy of nanoparticles considering both imaging power and 
radiosensitization potentialities still miss. However, some considerations may be 
drawn. Firstly, gold and gadolinium nanoparticles appear much more promising for 
theranostic radiosensitization than iron oxide nanoparticles as they can provide 
remarkable radiotherapy enhancement without any additional chemotherapy drug. 
Furthermore, gold nanoparticles have been reported to induce higher cell 
sensitization to radiations than gadolinium nanoparticles as gold nanoparticles 
scatter radiations more efficiently than gadolinium nanoparticles76. In fact, gold 
nanoparticles have larger scattering cross-section because Au (Z=79) is heavier 
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than Gd (Z=64) and atom packing is higher in gold nanoparticles than in gadolinium 
ones. On the other side, gadolinium nanoparticles allow real-time imaging by MRI, 
which is completely safe and non-invasive, while gold nanoparticles require the 
utilization of CT. Although the dose required for a single CT scan can be well-
tolerated, repeated scans over short time intervals may induce high probability of 
secondary tumour insurgence, especially in radiotherapy patients that are already 
exposed to high radiation doses. Therefore, real-time tracking of gold nanoparticles 
is more problematic if compared to gadolinium nanoparticles. Some studies reported 
the use of gadolinium-coated gold nanoparticles for dual CT and MR imaging, but 
they did not investigate the opportunity to use such nanoparticles for imaging-guided 
radiosensitization combining the safety of MR imaging and the high 
radiosensitization offered by gold77–79. 
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Chapter III 
 
Rationale, aims and organization of the research activity 
 
 
Previous studies reported the opportunity to use gadolinium nanoparticles and gold 
nanoparticles as theranostic nanoplatforms for imaging-guided radiosensitization. 
Beside the promising results, both nanoparticle types still present some limitations. 
In particular, gadolinium nanoparticles induce limited cell radiosensitization due to 
the low atomic number and atom packing density, while gold nanoparticles require 
the employment of CT imaging for nanoparticle-tracking with severe safety concerns 
for radiotherapy patients. In this work, gold-magnetite hybrid nanoparticles (H-NPs) 
are proposed as innovative agents for MRI-guided radiosensitization by combining 
the imaging properties of superparamagnetic magnetite and the radiosensitization 
potentialities offered by gold. As reported in Fig. 6, H-NPs are designed to infiltrate 
cancer tissue by passive targeting after intravenous injection. Following 
administration, nanoparticle biodistribution can be real-time monitored through the 
MRI-contrast enhancement offered by nanostructured magnetite. The imaging data 
should provide precise indications about the time evolution and the spatial profile of 
cancer radiosensitivity, enhanced by the gold contained in H-NPs. The real-time 
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picture of radiosensitivity profile across the tumour should allow the identification of 
the optimal time-point and dose shape for the optimization of the radiotherapy 
outcomes. The combination of safe real-time MR imaging and high-performance 
radiosensitization in a unique nanotool is expected to allow the personalization of 
radiotherapy together with a significant reduction of the radiation dose required for 
the local control of solid cancers compared to standard radiotherapy. This novel 
theranostic approach to radiotherapy claim to provide remarkable advances in the 
care of a wide range of solid radioresistant cancers with vasculature characteristics 
suitable for nanoparticle passive targeting. 
The purpose of this work is to demonstrate the suitability of hybrid nanoparticles for 
MRI-guided radiosensitization. In particular, the aims of the project include i) the 
development of a reproducible synthesis method for the production of cheap, 
properly-sized, well-dispersed and superparamagnetic gold-magnetite hybrid 
nanoparticles that match the requirements for cancer passive targeting, and ii) the in 
vitro testing of such nanoparticles for MRI-imaging and radiosensitization at the 
concentrations typically used in nanomedicine using a human 4T-MRI scanner and 
cell lines, selected as a model of radioresistant cancer (osteosarcoma). 
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Figure 6. Schematic representation of the proposed theranostic treatment for MRI-guided 
radiosensitization. 
To address these goals, the experimental work has been divided in three main 
steps: 
1) Synthesis of gold-magnetite hybrid nanoparticles by two different methods. 
The physico-chemical characterization of the nanoparticles was carried out 
and the results allowed the determination of the synthesis method for the 
production of most suitable gold-magnetite hybrid nanoparticles for our 
purposes. In particular, size and chemical composition of the resulting 
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nanoparticles were used as parameters for the selection of the synthesis 
method. 
2) Estimation of the magnetic properties of the gold-magnetite hybrid 
nanoparticles selected in the previous step. Nanoparticles were also tested 
in a 4T-MRI scanner approved for humans in order to assess the imaging 
potentialities of nanoparticles in the view of theranostic applications. 
3) Evaluation of cytotoxicity, cellular uptake and in vitro radiosensitization of 
the selected hybrid nanoparticles using human osteosarcoma MG63 cells 
and murine embryonic fibroblast NIH-3T3 cells. 
The experimental findings highlighted novelties in the field of nanoparticle chemistry 
regarding the production of hybrid nanoparticles suitable for cancer applications. 
Furthermore, the in vitro evaluations of the theranostic potentialities of our 
nanoparticles allowed preliminary considerations about the suitability of gold-
magnetite hybrid nanoparticles for MRI-guided radiosensitization. An extensive 
discussion of the findings of this work is delivered in the final chapter.  
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Chapter IV 
 
Synthesis and characterization of gold-
magnetite hybrid nanoparticles 
 
 
Two synthesis methods were tested for the production of hydrophilic gold-magnetite 
hybrid nanoparticles (H-NPs).  
The first one involved the reduction of gold(III) chloride by hydroxylamine in 
presence of prefabricated iron oxide nanoparticles in alkaline solution. In our 
previous study80, hydroxylamine-mediated gold reduction was demonstrated to 
induce the formation of gold star-shape nanostructures. Here, a similar procedure is 
used to synthetize H-NPs assuming that prefabricated iron oxide nanoparticles are 
embedded in the gold nanomatrices during gold growth process.  
The second synthesis method was based on a two-steps process. As first, oil-
soluble H-NPs were produced by thermal decomposition of metal precursors in a 
high-boiling point oil solution. Then, nanoparticles were dispersed in water by an 
innovative procedure based on polyoxyethylene(20) sorbitan monolaurate micelles. 
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Polyoxyethylene(20) sorbitan monolaurate is a non-ionic surfactant commonly used 
in a wide range of pharmacological applications and is known to be relative not-
toxic. The commercial name of polyoxyethylene(20) sorbitan monolaurate is 
Tween20. The chemical structure is reported in Fig. 7. The hydrophilic head is 
composed by polyethylene glycol moieties conjugated to a sorbitan, while the 
hydrophobic tail is a molecule of lauric acid. 
 
Figure 7. Chemical structure of Tween20. 
Morphology and chemical composition of nanoparticles produced by both synthesis 
methods were determined using transmission electron microscopy (TEM), energy 
dispersive x-rays analysis (EDXA), X-ray diffraction spectroscopy (XRD) and ion-
coupled plasma optical emission spectroscopy (ICP-OES). The hydrodynamic 
diameter in water and PBS solution of H-NPs synthetized by thermal decomposition 
method was evaluated by dynamic light scattering (DLS). Colloidal stability in protein 
solution was studied by the analysis of the optical absorption spectrum of 
nanoparticles at different time-points following nanoparticle incubation in cell culture 
medium. In fact, several experimental and theoretical studies have demonstrated 
that aggregation of plasmonic nanoparticles results in red shift and broadening of 
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plasmon absorption peak81,82. Unlike the case of DLS, the study of colloidal stability 
in protein solution by UV-visible spectroscopy does not require any purification steps 
that could perturb the final results. Therefore, UV-visible spectroscopy, although less 
informative, was preferred to DLS.  
The experimental results allowed the identification of the most suitable synthesis 
method for the production of nanoparticles appropriate for our purposes. 
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4.1. Materials and methods 
Chemicals 
All the chemicals were of reagent grade and were used without any further 
purification. 1-Octadecene (technical grade 90%), oleic acid (90%), oleylamine 
(70%), iron(III) acetylacetonate (97%), 1,2-hexadecanediol (90%), gold(III) chloride 
trihydrate (≥ 99.9%), sodium hydroxide, iron pentacarbonyl (99.99%), Tween20, 
alcohol isopropyl (≥99.8%), ethanol (99%), toluene, dimethyl sulfoxide (99%) and 
cyclohexane were purchased by Sigma Aldrich. Methoxy-terminated 1,2-distearoyl-
phosphatidylethanolamine-methyl-polyethylene glycol, MW 2500 Da, was purchased 
by Avanti Polar Lipids. Hydroxylamine hydrochloride (97%) was provided by 
Janssen Chimica. MG63 culture medium was prepared as described in Chapter VI. 
Below, the list of the abbreviations is reported.  
 
Compound Abbreviation 
1-Octadecene ODE 
Oleic acid OA 
Oleylamine OY 
Iron(III) acetylacetonate Fe(acac) 
Iron pentacarbonyl Fe(CO)5 
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Dimethyl sulfoxide DMSO 
Methoxy-terminated 1,2-distearoyl-
phosphatidylethanolamine-methyl-polyethylene 
glycol (MW 2,500 Da) 
DSPE-mPEG 
 
 
Hydroxylamine-based synthesis of H-NPs  
This method involved three main synthesis steps.  
1) Hydrophobic iron oxide nanoparticles were synthetized following the 
procedure reported by Sun et al83. A solution containing 700 mg Fe(acac), 
2.6 g 1,2-hexadencadiol, 2 ml OA, 2 ml OY and 20 ml ODE was stirred and 
heated to reflux under a nitrogen blanket. Initially, the solution was heated to 
200°C for 2 hours in order to promote thermal decomposition of Fe(acac), 
iron reduction by OY and nucleation of iron(0) atoms. Then, the solution was 
heated to 315°C for 1 hour to induce iron growth on the iron seeds. The 
solution was cooled down to room temperature maintaining the nitrogen 
blanket. One hour of air exposure was performed to allow iron oxidation. 
Furtherly, nanoparticles were flocculated by isopropyl alcohol, pelleted by 
centrifugation (30 min @ 6,000 rpm) and suspended in toluene. Toluene-
dispersed nanoparticles were flocculated by ethanol, pelleted by 
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centrifugation and suspended in toluene. The process was repeated three 
times. 
2) Phase transfer of iron oxide nanoparticles from the oil phase to water was 
performed using DSPE-mPEG micelles, as reported by Tong et al84. A 
solution of 2.4 ml chloroform containing DSPE-mPEG (0.5 mg/ml) was 
mixed to 0.6 ml magnetite nanoparticles (5 mg/ml). Under nitrogen blanket, 
12 ml DMSO was gradually added under stirring. Then, chloroform was 
evaporated under nitrogen flux and 24 ml water was gradually added to the 
solution. Nanoparticles were purified by filtration (0.2 μm cellulose filter) and 
centrifugation (1h @ 40,000 rpm) in order to remove empty DSPE-mPEG 
micelles and nanoparticle aggregates. 
3) Gold-magnetite hybrid nanoparticles were obtained by dropwise addition of 
hydroxylamine in a alkaline solution of gold(III) chloride, sodium hydroxide 
and DSPE-mPEG-stabilized iron oxide nanoparticles. The details of the 
procedure is covered by a European patent (WO 2014122608 A1). The 
resulting H-NPs were purified by magnetic separation and centrifugation to 
remove residual reagents. 
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Thermal decomposition synthesis of H-NPs 
Oil-soluble H-NPs were synthetized as reported by Yu et al85. Briefly, a mixture of 20 
ml ODE, 2 ml OA, 2 ml OY and 2 g 1,2-hexadecanediol was heated to reflux at 
190°C under nitrogen blanket for 20 min. Then, 0.3 ml Fe(CO)5 was added and, 
after 3 min, a solution of 40 mg gold(III) chloride dispersed in 5 ml ODE and 0.5 ml 
OY was poured in the mixture. Immediately after gold addition, the solution turned to 
red color as gold seeds formed. The solution was heated for 45 min at 315°C 
allowing the growth of the magnetite nanocrystal on the surface of the gold. In Fig. 8, 
a picture of the synthesis apparatus is reported. At the end of the process, the 
solution was cooled down to room temperature under nitrogen flow and 1h air 
exposure was performed to allow iron oxidation. The resulting nanoparticles were 
purified several times by flocculation (isopropyl alcohol and ethanol) and 
centrifugation (30 min @ 6,000 rpm). Finally, H-NPs were suspended in 20 ml 
toluene.  
The oil-to-water transfer of H-NPs was carried out following a modified version of the 
procedure developed by Jin et al86. An aliquot of 5 ml H-NP solution was precipitated 
by centrifugation (30 min @ 6,000 rpm) after ethanol-induced flocculation and 
suspended in 1.0 ml cyclohexane. Then, the H-NP solution was added to 30 ml 
water and 150 µl Tween20. The mixture was sonicated for 20 min with a tip 
sonicator and placed at 85°C under nitrogen blanket for about 2 hours to evaporate 
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the cyclohexane. The resulting hydrophilic Tween20-capped H-NPs were purified by 
centrifugations (1h @ 20,000 rpm) and filtration.  
 
 
Figure 8. Experimental apparatus for the synthesis of hydrophobic H-NPs. The same 
apparatus was used for the synthesis of hydrophobic iron oxide nanoparticles. 
 
Nanoparticle characterization 
The morphology and the elemental composition of nanoparticles were studied using 
a Philips CM12 transmission electron microscope (TEM) operated at 120 kV and 
equipped with a system for energy-dispersive X-rays analysis (EDXA). Drops of 
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nanoparticle solutions were placed on carbofilm-coated copper grids and the 
solvents were evaporated before the analysis.  
XRD analysis was performed on a thick layer of iron oxide nanoparticles and 
thermodecomposition-synthetized H-NPs, deposited on a silicon substrate, to study 
the crystalline structure of nanoparticles. The analysis was carried out using an Ital 
Structures APD2000 XRD instrument, in the parallel beam configuration. 
The metal composition of both types of H-NPs was obtained by dissolving 
nanoparticles in aqua regia and analysing the dissolved solutions by a Spectro Ciros 
ICP-OES. The analysis was repeated for each synthesis batches to assess the 
reproducibility of the process.  
Hydrodynamic diameter of Tween20-stabilized nanoparticles in water and 
phosphate-buffer (PBS) solution was acquired by a Zetasizer ZS dynamic light 
scattering (Malvern).  
The evaluation of colloidal stability of Tween20-stabilized nanoparticles in protein 
solution was performed by incubating nanoparticles in MG63 cell culture medium for 
two days @ 37°C. Aliquots were withdrawn at different time-points (0h, 2h, 6h, 24h 
and 48h) and the optical absorption spectra were acquired by Tecan Microplate 
Reader. The absorption spectrum of nanoparticles dispersed in PBS was acquired 
for comparison.   
 68 
4.2. Results 
Iron oxide nanoparticles were produced for being used as reagent in the further 
synthesis of H-NPs. In the left part of Fig. 9, the characterization of the morphology 
and crystalline structure of oil-soluble iron oxide nanoparticles is reported. The 
transmission electron micrograph (Fig. 9A) confirms the formation of cubic-like 
nanostructures with average side length of 8.6 nm, as shown by the numerical size 
distribution (Fig. 9C). The XRD analysis (Fig. 9E) conducted on iron oxide 
nanoparticles confirms the achievement of magnetite nanocrystals. The large 
contribution of the amorphous phase arises from the OA-shell surrounding iron oxide 
nanoparticles87. The nanoparticles were furtherly transferred in water by DSPE-
mPEG micelles and used as reagents for the synthesis of hybrid nanoparticles by 
hydroxylamine-mediated gold reduction in alkaline solution. The TEM image of the 
synthesis products (Fig. 9B) assesses the formation of gold-based nanostars with 
average diameter of 63 nm, as shown by the numerical size distribution (Fig. 9D). 
The EDXA spectrum (Fig. 9F) confirms the presence of iron and gold in the sample, 
although the iron signal is almost negligible.  
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Figure 9. Morphological and chemical characterization of oil-soluble iron oxide 
nanoparticles (left) and hybrid nanoparticles produced by hydroxylamine-mediated gold 
reduction (right). In the upper part of the panel, transmission electron micrographs (A, B) of 
nanoparticles and numerical size distributions (C, D) are reported. In the bottom part, XRD 
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spectrum of iron oxide nanoparticles (E) and the EDXA data referred to H-NPs (F) are 
shown. 
The results of TEM, XRD and EDXA analysis on hydrophobic nanoparticles 
produced by thermal decomposition of metal precursors are reported in Fig. 10.  
 
Figure 10. Morphological and chemical characterization of hydrophobic H-NPs synthetized 
by thermal decomposition. In the upper part, TEM image of nanoparticles (A) and numerical 
size distribution (B) are reported. In the bottom part, EDXA results (C) and XRD spectrum 
(D) of nanoparticles are shown. 
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TEM investigation highlights the formation of dumbbell-like nanostructures 
composed by a spherical gold part (the more contrasted one) and by an irregular 
iron oxide part (Fig. 10A). The hybrid nanostructures have an average diameter of 
12.6 nm (Fig. 10B). EDXA analysis (Fig. 10C) confirmed the presence of gold and 
iron while XRD data assessed the iron oxidation in the form of magnetite (Fig. 10D). 
The data about the metal composition of nanoparticles synthetized by both methods 
are reported in Table 1.  
 
 Batch Gold (% wt.) Iron (% wt.) Others (% wt.) 
Hydroxylamine-based 
method 
#1 98.8 0.1 <0.1 
Thermodecomposition-
based method 
#1 67.1 32.8 <0.1 
#2 60.9 39.0 <0.1 
 
Table 1. Percent content of gold, iron and other metals in nanoparticles produced by 
hydroxylamine-based method and thermodecomposition-based method. The analysis was 
performed by ICP-OES on samples derived by different synthesis batches.  
Negligible traces of metals different from gold and iron were detected in the samples 
confirming the absence of potentially dangerous residual metals after nanoparticle 
purification. The ICP-OES analysis of nanoparticles, produced by hydroxylamine-
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based method, evidenced that nanoparticles are composed mainly by gold (98.8% 
wt.), while iron content is almost negligible. On the other side, nanoparticles, 
produced by thermodecomposition-based method, are composed by ~65% wt. gold 
and 35% wt. iron. Two different synthesis batches of those nanoparticles were 
produced and analysed providing similar results in terms of metal composition. 
Moreover, thermodecomposition synthesis method provided higher synthesis yield 
(~70% wt. metal precursors was transformed in nanoparticles) than the 
hydroxylamine-based methods.  
Colloidal stability and hydrodynamic diameter of Tween20-capped dumbbell-like H-
NPs was assessed in water and PBS solution by DLS. The results, reported in Fig. 
11, highlight nanoparticles have a hydrodynamic diameter of ~30 nm and do not 
form aggregated either in water either in PBS. 
Considering the impact that proteins could have on nanoparticles stability, the 
optical response of Tween20-capped dumbbell-like H-NPs incubated in MG63 cell 
culture medium was evaluated at different time-points. The UV-visible absorbance 
spectra of nanoparticles after 0h, 2h, 6h, 24h and 48h of incubation in cell culture 
medium are reported in Fig. 12. No changes in the optical absorption profile of 
nanoparticles occur over all the time-points and the profiles of nanoparticles in PBS 
and cell culture medium match well. In particular, no broadening or shift of the SPR 
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band occurs suggesting that Tween20 coating confers stealth properties to 
nanoparticles hindering nanoparticle agglomeration.  
 
Figure 11. DLS analysis of Tween20-capped dumbbell-like H-NPs dispered in water (blue 
line) and PBS solution (red line). 
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Figure 12. UV-visible absorption spectra of Tween20-capped dumbbell-like H-NPs at 
different time-points (0h, 2h, 6h, 24h and 48h) following incubation of nanoparticles in MG63 
cell culture medium and PBS (0h). The spectra are nudged to allow a better visualization.  
 75 
4.3. Discussion 
Hydrophilic gold-magnetite hybrid nanoparticles were synthetized by two synthesis 
methods. In particular, star-shape H-NPs were produced by a procedure involving 
the reduction of gold(III) chloride by hydroxylamine in presence of prefabricated iron 
oxide nanoparticles. Tween20-stabilized dumbbell-like H-NPs were synthetized by 
thermal decomposition of metal precursors in oil and transferred in water by 
Tween20 micelles. Nanoparticles produced by thermal decomposition method are 
smaller than nanoparticles produced by hydroxylamine-based method. In particular, 
the size of dumbbell-like H-NPs (12.6 nm) has been demonstrated to be better for 
nanoparticle-mediated radiosensitization70. Moreover, dumbbell-like H-NPs present 
a balanced gold and iron content (65% Au, 35% Fe), while star-shape H-NPs are 
composed by an extremely low iron amount (less than 1%). The poor iron content 
direct influences the magnetic properties and limits MR imaging potentialities.  
In addition, Tween20-stabilized dumbbell-like H-NPs provide excellent colloidal 
stability in water and in physiological solution. Nanoparticles remained stable also in 
protein solution for up to two days confirming the efficacy of Tween20-capping in 
stabilizing nanoparticles, as expected by capping molecules composed by 
polyethylene glycol moieties.  
As a consequence of the results so far presented, Tween20-capped dumbbell-like 
H-NPs were selected as candidates for MRI-guided radiosensitization and, in the 
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following dissertation, Tween20-stabilized dumbbell-like H-NPs will be named, 
simply, as H-NPs.  
 77 
Chapter V 
 
Study of the magnetic properties and the 
imaging potentialities of H-NPs 
 
 
A fundamental issue in theranostic nanoparticles for radiotherapy enhancement 
regards the possibility to finely determine the biodistribution of nanoparticles 
following administration. In particular, the precise tracking of nanoparticle 
accumulation in cancer and surrounding tissues is expected to provide useful 
information to the physicians about the sensitization profile obtained in the target 
tissues allowing the optimization and the standardization of the dose delivery in 
radiotherapy.  
Once injected in the blood, H-NPs are designed to be tracked by MR imaging 
exploiting the superparamagnetic properties of nanosized magnetite. Under an 
applied magnetic field, the magnetic momentum of superparamagnetic nanoparticles 
is aligned in the direction of the field inducing spatio-temporal inhomogeneities in the 
local magnetic field. Such inhomogeneities perturb the nuclear spin relaxation 
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process of H1 protons of water molecules surrounding nanoparticles promoting the 
dephrasing of transverse proton spins. This effect results in the shortening of the 
spin-spin relaxation time (T2) and consequent darkening (negative contrast 
enhancement) of the T2-weighted MR image. Typically, MRI sequences for the 
acquisition of T2-weighted images are optimized to reduce as much as possible the 
dephasing effects of local magnetic inhomogeneities. When superparamagnetic 
contrast agents are used, the MRI signal arising from transverse magnetization of 
proton spins is acquired without any spin rephrasing expedient, using so-called T2*-
weighted acquisition sequences.  
The potentialities of H-NPs as contrast agents in MRI depend on their magnetic 
properties. In this section, the magnetic behaviour of H-NPs was assessed by the 
measurement of the magnetic hysteresis curve of nanoparticles and by the study of 
the influence of H-NPs on H1 water proton spin-spin relaxation by nuclear magnetic 
resonance spectroscopy (NMR) investigations. The results were compared to 
literature values referred to other superparamagnetic nanoparticles for MR imaging. 
Furthermore, H-NPs were tested in a 4T-MRI whole-body scanner to investigate the 
dependency of imaging contrast enhancement to H-NP concentration using a typical 
T2*-weighted acquisition sequence.  
 79 
5.1. Materials and methods 
The magnetization curve of H-NPs was evaluated using an alternating gradient force 
magnetometer (AGFM) provided by the IMEM-CNR Center of Parma (Italy). The 
measurement was performed at room temperature.  
The effect of H-NPs on the spin-spin relaxation time (T2) of H1 water protons was 
investigated using a Bruker 400WB instrument, working at 400.13 MHz proton 
frequency. NMR spectra were acquired with single pulse, Car-Purcel-Meiboom-Gill 
echo train acquisition and inversion recovery sequences under the following 
conditions: 4.9 μs π/2 pulse, 10 s recycle delay, 8 scans. The T2 relaxation times of 
four nanoparticles samples at different iron molar concentrations (0, 0.125, 0.250, 
0.500 mM) were calculated and the data were fitted in order to estimate the spin-
spin relaxivity (r2). Spin-spin relaxivity is defined by the equation 1/T2 = 1/T20 + 
r2·[Fe], where T2 and T20 are the relaxation time of sample and pure water, 
respectively, and [Fe] is the iron molar concentration of H-NPs.  
A 4T-MRI Bruker Spec Med scanner, provided by MR Lab of the Center for 
Mind/Brain Sciences (University of Trento, Italy), was used to acquire the MRI-
images of a phantom. The phantom consisted of a set of plastic tubes (syringes 
filled by 5 ml and sealed with impermeable tape) loaded with different concentrations 
of H-NPs (0.0, 1.7, 8.5, 17.0, 84.8 μg/ml). The array of tubes was positioned within a 
larger cylindrical recipient (25 cm height, 11 cm diameter), filled with water. The 
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whole phantom simulated biological tissues and kept the set of syringes positioned 
as a parallel array during the MRI acquisition (Fig. 13). Each syringe was carefully 
filled to minimize air bubbles that could affect the homogeneity of the magnetic field 
in the phantom. A standard anatomical T2*-weighted spin-echo sequence (TE = 44 
ms, TR = 49 ms) was used to acquire the MR image of the phantom. Voxel size was 
0.18 cm x 0.18 cm x 0.1 cm and 72 slices were acquired. The contrast enhancement 
provided by nanoparticles was evaluated in terms of the normalized brightness 
variation in function of the H-NP metal concentration. The H-NP concentration 
values are expressed in terms of total metal concentration (CH-NPs = CAu + CFe). 
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Figure 13. MRI phantom used in 4T-MRI scanner. Inside the phantom, a sample holder 
maintained the tubes parallel. In the box, a zoom of the plastic tube loaded with H-NP 
solution.  
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5.2. Results 
The field-dependent magnetization curve of H-NPs is reported in Fig. 14A. At room 
temperature, negligible hysteresis is observed. This evidence is consistent with the 
hypothesis that nanoparticles are in the superparamagnetic state. The AGFM 
measurement shows saturation magnetization value of ~35 emu per gram of iron 
saturation magnetization value and coercivity value of ~15 kOe. As expected from 
superparamagnetic nanoparticles, the relaxation rate (1/T2) of H1 water protons 
increased by increasing the concentration of H-NPs. The NMR data are shown in 
Fig 14B and, as result of linear regression analysis, 156.4 mM-1s-1 r2 value was 
obtained. These results compare well with previously reported literature values88–90. 
 
 
Figure 14. Magnetization curve of H-NPs measured at room temperature (A) and transverse 
relaxation rates (1/T2) vs. Fe concentration measured at 9.4 T.  
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The contrast enhancement of H-NPs was investigated using a 4T-MRI whole-body 
scanner. A T2*-weighted image of a phantom loaded with samples at different 
nanoparticle concentrations was acquired. In Fig 15A, the MRI-images of a 
transverse section of the samples are shown. In Fig 15B, the normalized brightness 
of the samples is plotted in function of nanoparticle concentration. The trend follows 
an exponential decay of the normalized brightness versus nanoparticle 
concentration. Under those acquisition parameters, a detection limit of 
approximately 8 μg/ml H-NPs was estimated. 
 
 
Figure 15. T2*-weighted MR image of a transverse section of H-NP samples (A). The 
grayscale defines the normalized brightness. Average and SD normalized brightness of the 
imaging area referred to each sample are reported in function of H-NP concentration.    
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5.3. Discussion 
The magnetic properties of gold-magnetite hybrid nanoparticles synthetized by 
thermal decomposition method and stabilized in water by Tween20 micelles were 
studied. The results highlighted that H-NPs are in the superparamagnetic state at 
room temperature with magnetization saturation value and coercivity value 
consistent with the values previously reported in literature for superparamagnetic 
nanoparticles. The influence of water-dispersed H-NPs on the spin-spin relaxation of 
H1 water protons was studied by NMR spectroscopy. The measurement provided a 
value of r2 relaxivity similar to the typical relaxivity values of previous reported 
magnetite nanoparticles for MR-contrast imaging. Finally, H-NPs were tested in a 
real-case configuration using a whole-body 4T-MRI scanner showing an exponential 
decay trend between the contrast enhancement in the T2*-image and the H-NP 
concentrations in the examined samples. Approximately 8 ug/ml H-NPs was 
estimated as the minimum detectable H-NP concentration. The detection limit of H-
NPs is similar to that of gadolinium nanoparticles in T1-weighted images as reported 
by Le Duc et al confirming H-NPs provide imaging potentialities comparable to those 
offered by gadolinium nanostructures74.   
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Chapter VI 
 
Biological evaluations 
 
 
Gold-magnetite hybrid nanoparticles could potentially provide relevant advances in a 
wide range of oncologic diseases. In particular, H-NPs are expected to successfully 
operate as MRI-contrasted radiotherapy adjuvants in case of solid cancers with 
certain anatomical and physiological features, including defective blood vessel 
architecture (enhanced permeability and retention effect) and radioresistance.  
Osteosarcoma, an aggressive solid bone cancer with an incidence rate of 
approximately 5.0 per year per million persons for the range 0-19 years91, 
represents an optimal candidate for the implementation of theranostic H-NPs. In 
fact, previous in vivo studies regarding curcumin liposomes and polymer 
nanoparticles for osteosarcoma care revealed that osteosarcoma can be effectively 
targeted by nanoparticles through passive targeting92,93. In addition, osteosarcoma 
cells are known to be particularly radioresistant, limiting the use of radiotherapy in 
lesions occurring in the extremities, the base of skull, the pelvis and the neck, where 
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satisfactory surgical resection is difficult to achieve with acceptable margins94. 
Successful osteosarcoma radiotherapy requires high radiation dose delivery with 
consequent risk of adverse events in the surrounding healthy tissues95,96. In this 
scenario, theranostic H-NPs could provide osteosarcoma radiosensitization enabling 
precise dose shaping and optimal radiotherapy timing by real-time MRI-tracking of 
nanoparticle distribution in the cancer lesion.  
In this section, the potentialities of H-NPs for osteosarcoma radiosensitization are 
investigated in vitro using human osteosarcoma MG63 cells. In addition, parallel 
biological evaluations were conducted on murine embryonic fibroblast 3T3 healthy 
cells in order to estimate possible drawbacks related to H-NPs utilization. In fact, 
osteosarcoma radiotherapy is often followed by orthopedic surgery for cancer 
resection and fibroblasts play a fundamental role in the first stages of bone healing, 
as they are a source of osteoblast precursors. Therefore, any osteosarcoma 
treatment should prevent as much as possible any damages to fibroblast population 
in order to reduce the recovery time following osteosarcoma resection.  
Biological assays were performed on MG63 cells and 3T3 cells in order to estimate 
potential cytotoxicity of H-NPs at nanoparticle concentrations typically used in 
medical applications. Cytotoxicity was evaluated in terms of cell membrane integrity 
and cell morphology changes following incubation with cell media loaded with 
nanoparticles. Cell membrane integrity was measured by lactase dehydrogenase 
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(LDH) assay that estimates the amount of cytoplasmic lactase dehydrogenase 
enzyme released in the culture supernatant as result of cell apoptosis or necrosis. 
Cell morphology was investigated by laser scanning confocal microscopy on 
nanoparticle-exposed cell cultures, stained with cytoskeleton-specific and nuclei-
specific fluorescent dyes. Confocal microscopy was also used to assess the 
intracellular distribution of fluorescence-labelled nanoparticles allowing 
considerations about the internalization processes occurring in cellular uptake of 
nanoparticles. The potentialities of H-NPs for cellular radiosensitization were 
evaluated by viability assay performed on clonogenic cell cultures, incubated with 
nanoparticles and treated with megavoltage radiotherapy. Due to the lag time 
between the irradiation and the occurrence of radiation damages in the cells, 
clonogenic assays are commonly used in radiobiology as they provide a reliable 
estimation of long-term effects of radiations in cell cultures. In radiobiological 
clonogenic assays, cells are irradiated and reseeded using low cell density. Then, 
cell viability is estimated after some days from the irradiation. In our experiment, 
alamar blue kit assay was used to measure clonogenic cell viability after five days 
from irradiation. In particular, alamar blue allowed the determination of cellular 
metabolic activity in the clonogenic cultures. Although metabolic activity assays are 
not the standard goal for radiobiological clonogenic experiments, a previous study of 
Anoopkumar-Dukie et al demonstrated that the results of alamar blue-like assays 
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are consistent with convectional assays for the estimation of cell surviving fraction 
and cell proliferation, including microscope counting of stained cells or other assays 
aimed to measure the synthesis rate of new DNA in cell cultures97. The results are 
briefly discussed to evaluate the potential implementation of H-NPs in the clinical 
management of osteosarcoma.   
 89 
6.1. Materials and methods 
Cell cultures 
Human bone osteosarcoma MG63 cells and immortalized mouse embryonic 
fibroblast 3T3 healthy cells were employed for the in vitro tests. MG63 cells were 
cultured using MEM, supplemented with 10% fetal calf serum, 1% sodium pyruvate, 
1% MEM NEAA 100x, 1% L-glutamine and 1% penicillin–streptomycin. 3T3 cells 
were cultured using DMEM supplemented with 10% fetal calf serum, 1% sodium 
pyruvate, 1% L-glutamine and 1% penicillin-streptomycin. Cell cultures were 
maintained in humidity-controlled incubator at 37°C and 5% CO2. 
 
Lactase dehydrogenase assay 
LDH in vitro assay (Kit TOX7, Sigma-Aldrich) was used to evaluate the short-term 
cytotoxicity of H-NPs. The kit allows the quantification in the cell culture supernatant 
of lactate dehydrogenase (LDH), a cytoplasmic enzyme used as marker of cell 
integrity. LDH enzyme is released by cells in case of damage to the cell membrane. 
To perform the LDH assay, 2×104 cells/cm2 was seeded and, after 24h, cells were 
exposed for 48h to culture media loaded with H-NPs at nanoparticle concentrations 
of 10 µg/ml, 50 µl/ml and 100 µg/ml. The H-NP concentration values are expressed 
in terms of total metal concentration (CH-NPs = CAu + CFe). The concentration values 
were chosen according to previous studies about in vitro tests of hybrid 
 90 
nanoparticle89,98. The LDH test was performed following the manufacturer’s 
instructions. Negative (cells cultured in normal conditions) and positive (complete 
loss of membrane integrity) controls were used to test the assay robustness. Cells 
cultured with nanoparticle-free medium were used as negative controls. Cells 
incubated with culture medium loaded with 0.5% w/v Triton-X, a non-ionic surfactant 
able to permeabilize cell membrane, were used as positive controls.  
 
Confocal laser scanning microscopy 
Cell morphology and cellular internalization of nanoparticles following H-NP 
incubation were evaluated by laser scanning confocal microscopy, using a Nikon 
Eclipse Ti-E system. H-NPs were preliminary stained with DiI (1,1′-didodecyl-
3,3,3′,3′-tetramethylindocarbocyanine perchlorate, Invitrogen), a hydrophobic dye 
suitable for fluorescence labelling of nanoparticles. In particular, DiI molecules are 
embedded in H-NPs and segregated at the hydrophobic interface among the metal 
surface and the lauric acid moities of Tween20 molecules. The staining process was 
carried out as suggested by Landazuri et al99: H-NPs were incubated overnight with 
20 µg/ml DiI solution and washed by centrifugation. Then, 2×104 cells/cm2 were 
seeded on 8-wells glass chamber slide (Thermo Scientific, USA) and, after one day 
from the seeding, they were exposed for 24h to culture medium loaded with 100 
µg/ml DiI-stained H-NPs. Cells were washed several time with PBS, fixed with 4% 
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formaldehyde and permeabilized with Triton-X (0.2% w/v in PBS). 4’,6-diamino-2-
phenylindole DAPI (Sigma-Aldrich) and Oregon Green® 448 phalloidin (Invitrogen, 
Life Technologies) were used to stain the nuclei and the cytoskeleton actin 
filaments, respectively.  
 
Alamar blue assay  
A clonogenic assay was performed to evaluate the radiosensitizing potentialities of 
H-NPs in MG63 and 3T3 cell cultures. 8×104 cells/well was seeded in a 12-well-
tissue culture plate. After 24h from the seeding, the medium was removed and fresh 
medium, loaded with H-NPs at different concentrations (0 μg/ml, 1 μg/ml, 10 μg/ml, 
100 μg/ml), was added. Following 24h exposure to NP-loaded medium, cell cultures 
were transferred to the Radiotherapy Department of Santa Chiara Hospital (Trento, 
Italy) for the irradiation. An Elekta Precise Treatment System equipment was used to 
irradiate cells with 10 Gy radiation dose, 6 MVp peak energy. A radiation field of 
20x20 cm was used. The electronic equilibrium in the cell cultures was ensured by 
placing cell culture plates into a properly designed phantom as shown in Fig 16.  
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Figure 16. Experimental set up used for the irradiation of cell cultures. In the box, the 
plexiglas phantom used to ensure the electronic equilibrium in cell cultures during the 
irradiation. 
Immediately after irradiation, the medium was removed and cells were detached by 
Trypsin 0.05% w/v, counted and reseeded in 48-well tissue-culture plates using 
fresh NP-free medium. Considering the different proliferation rate of MG63 cells and 
3T3 cells, two seeding densities were used depending on the cell type. In particular, 
5×103 cells/well and 5×102 cells/well seeding density were used for MG63 cells and 
for 3T3 cells, respectively. At day 3 after reseeding, the medium was removed and 
fresh medium was added. At day 5, cell viability was assessed by alamar blue kit 
assay (Biosource International, USA), following the manufacturer’s instructions. 
Alamar blue assay is based on the ability of viable and metabolically active cells to 
reduce resazurin by mitochondrial, microsomal and cytosolic oxidoreductases. The 
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reduction of resuzin results in the formation of resorufin, a fluorimetrically 
measurable compound.  
 
Statistical analysis 
All values are listed as mean and standard deviation (SD). Statistical analysis was 
performed on the LDH and alamar blue results. In the case of alamar blue, the group 
sets referred to 0 Gy-treated and 10 Gy-treated samples were analysed separately. 
Unpaired t-test with equal variances, adjusted by Bonferroni correction, was used 
with a 0.05 significance level.  
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6.2. Results 
Membrane integrity of MG63 cells and 3T3 cells after 48h exposure to different 
concentrations of H-NPs was tested using lactate dehydrogenase (LDH) assay. The 
LDH data are reported in Fig. 17 and are directly proportional to the number of dead 
cells. No significant differences in LDH leakage into the media was detected over all 
the range of nanoparticle concentrations and the negative control either for MG63 
cells and 3T3 cells. The results were consistent to previous studies regarding 
cytotoxicity induced by iron oxide and gold nanoparticles20. In particular, the LDH 
assay confirmed that no unsafe contaminations occurred in the synthesis of 
nanoparticles, although Tween20 had been discovered to induce moderated 
cytotoxicity100.  
The study of the cellular uptake process was conducted by confocal laser scanning 
microscopy on MG63 cells and 3T3 cells using DiI-labelled H-NPs. Following 24h 
incubation, H-NPs are taken up either by MG63 cells and 3T3 cells as shown by 
confocal laser images, reported in Fig. 18 and Fig. 19. In particular, internalized 
nanoparticles appeared clustered in localized intracellular compartments. This 
evidence is consistent to previous studies that identified lysosomes as the 
preferential accumulation sites for nanoparticles taken up by pinocytosis 
mechanism101. The comparison among confocal images of cells exposed to 
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nanoparticles and the controls did not reveal remarkable changes in cell morphology 
indicating H-NP safety.  
The synergetic effect of H-NPs and megavoltage radiations on cell viability was 
evaluated by alamar blue assay on clonogenic MG63 and 3T3 cell cultures exposed 
to different concentrations of H-NPs and irradiated with 10 Gy radiation dose (6 
MVp). The results, reported in Fig. 20, highlight nanoparticles alone do not affect cell 
viability either in MG63 and 3T3 cells confirming that H-NPs as well are safe. The 
comparison between the group sets referred to RT-treated samples and the not-
treated ones reveals that radiotherapy induced a dramatically decrease of cell 
viability in all samples. Approximately 20% and 28% reduction of MG63 cell viability 
occurred in RT-treated samples incubated with H-NP-loaded media, respectively at 
10 μg/ml and 100 μg/ml nanoparticle concentration, compared to RT-treated 
samples cultured in NP-free medium. This evidence supports the hypothesis that H-
NPs enhance radiation toxicity in osteosarcoma cells. On the contrary, no significant 
differences were detected in 3T3 cell cultures treated with nanoparticles and 
radiations versus cells treated with radiotherapy only, indicating H-NPs do not 
induce radiosensitivity enhancement in fibroblast cells. The statistical difference in 
RT-treated cells incubated with 1 μg/mg nanoparticles versus cells treated with RT 
only is probably due to an error in the number of cells reseeded after radiotherapy. 
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Figure 17. LDH assay performed on MG63 cell line (A) and 3T3 cell line (B). Negative and 
positive control consisted of cells cultured with NP-free medium and with Triton-X-enriched 
medium, respectively. (n=6). ***p<0.001 versus the negative control. 
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Figure 18. Confocal laser scanning microscopy of MG63 cells cultured with NP-free medium 
(on the left) and 24h exposed to NP-loaded medium (on the right). Cells were stained with 
DAPI (blue) and Oregon Green (green), while H-NPs were stained by DiI (red). On the 
bottom part, the images are reported without Oregon Green staining. The arrows indicate 
the presence of H-NPs. 
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Figure 19. Confocal laser scanning microscopy of 3T3 cells cultured with NP-free medium 
(on the left) and 24h exposed to NP-loaded medium (on the right). Cells were stained with 
DAPI (blue) and Oregon Green (green), while H-NPs were stained by DiI (red). On the 
bottom part, the images are reported without Oregon Green staining. The arrows indicate 
the presence of H-NPs. 
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Figure 20. Alamar blue performed on MG63 cells (A) and 3T3 (B) following 24h exposure to 
NP-loaded medium at different H-NP concentration (0, 1, 10, 100 μg/ml), treated with 0 Gy 
and 10 Gy radiation dose. (n=6). *p<0.05, **p<0.01, ***p<0.001 versus 0 μg/ml group 
treated with 10 Gy.  
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6.3. Discussion 
The biological assays performed on MG63 cells and 3T3 cells confirmed that H-NPs 
do not induce cytotoxicity in both cell lines examined in this study. In particular, LDH 
assay, confocal laser scanning microscopy and alamar blue assay revealed no 
change in membrane integrity and morphology following nanoparticles exposure, 
even for high nanoparticle concentration (100 μg/ml). The results were consistent to 
previous cytotoxicity studies of gold and iron oxide nanoparticles20. In addition, 
confocal laser scanning microscopy assessed the internalization of fluorescence-
labelled H-NPs and the evidence of nanoparticle segregation in specific cellular 
compartments suggests that pinocytosis could be the main mechanism occurring in 
the uptake process.  
The potentialities of H-NPs for radiosensitization were investigated by the 
measurement of cell viability in clonogenic MG63 and 3T3 cell cultures exposed to 
H-NPs and irradiated by 10 Gy radiation dose. No synergetic effect of H-NPs and 
radiations was highlighted in fibroblast cell line while approximately 20% and 28% 
reduction of cell viability was estimated in radiotherapy-treated osteosarcoma cell 
cultures incubated with 10 μg/ml and 100 μg/ml nanoparticle concentrations 
compared to cell cultures treated with radiotherapy only. Therefore, a selective 
radiosensitization activity of H-NPs was demonstrated to occur in osteosarcoma 
cells, although the mechanisms of such selectivity are still not clear and more 
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studies are required for a deep understanding of the sensitization process. The 
results of radiobiological assay, although very preliminary, confirmed the 
potentialities of H-NPs for osteosarcoma radiotherapy. In fact, H-NPs were proven to 
enhance the outcomes of radiotherapy in osteosarcoma cells without affecting a 
fundamental resource for post-surgery recovery. However, convectional 
radiobiological assays, based on the estimation of cell proliferation and survival after 
irradiation, are needed to confirm the results of our metabolic activity assay. 
As reported in literature, other cell types are well sensitized by gold nanoparticles. 
For instance, cell lines derived from prostate, breast and cervical cancers have been 
experience high radiosensitization if cultured in gold nanoparticle-enriched media68–
70. Thus, beside osteosarcoma, H-NPs claim to be a successful tool for the 
radiosensitization of a wide range of cancer types.  
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Chapter VII 
 
Conclusions 
 
 
Theranostics defines a class of medical methods based on the use of therapeutic 
agents able to test the patient’s response to the therapy, allowing treatment 
modulation and personalization. Recently, nanoparticles have been identified as 
promising platforms for cancer theranostics, thanks to their peculiar biological 
mobility and physico-chemical properties. In particular, properly designed 
nanoparticles have been proven to selectively target solid cancers as the defective 
architecture of tumour blood vessels allows the extravasation and retention of 
nanoparticles in the cancer (EPR effect), while normal tissues are generally 
preserved from nanoparticle accumulation.  
In this work, gold-magnetite hybrid nanoparticles (H-NPs) are proposed as 
innovative theranostic tools for imaging-guided radiosensitization. The biphasic 
structure of H-NPs combines the potentialities of superparamagnetic magnetite 
nanoparticles for MR imaging and the radiosensitization performances of gold 
nanoparticles in a unique nanoplatform. The imaging power of magnetite 
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nanoparticles is well-known and arises from the ability of superparamagnetic 
nanoparticles to induce contrast enhancement in T2*-weighted MR images. On the 
other hand, gold nanoparticles are efficient x-ray absorber and, once internalized in 
cells, induce concentration-dependent radiosensitization by enhancing local 
deposition of radiation dose. The combination of imaging and radiosensitization 
offered by H-NPs should allow the implementation of effective theranostic 
radiosensitization. In particular, the biodistribution of blood-injected H-NPs is 
trackable by MR imaging, providing a real-time picture of the radiosensitivity profile 
across the tumour lesion. The imaging data can be used to determine the optimal 
time-point and radiation shape in radiotherapy, allowing a significant reduction of the 
radiation dose required for cancer local control in comparison to standard 
radiotherapy. Theoretically, H-NPs are expected to perform better than convectional 
low-molecular-weight radiosensitizers and other theranostic nanoparticles, like gold 
and gadolinium nanoparticles. In particular, compared to molecular drugs, H-NPs 
should offer higher radiosensitization performances and the opportunity for 
treatment personalization. Furthermore, H-NPs are expected to overcome the 
limitations imposed by gold nanoparticles and gadolinium nanoparticles in terms of 
safety concerns due to CT imaging and poor radiosensitization, respectively. 
The experimental work was set up to address the following aims: 
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i) to synthetize H-NPs able to match the requirements of size, chemical 
composition, colloidal stability, and magnetic properties highlighted by 
previous studies about medical nanoparticle for MR imaging and 
radiosensitization.  
ii) to deliver preliminary in vitro evaluations about biosafety, imaging 
potentialities, radiosensitizing performances of H-NPs using clinical MRI 
scanner and osteosarcoma-model cell lines.  
 
Two innovative synthesis methods have been tested to achieve H-NPs suitable for 
our purposes. The first method involved gold reduction on prefabricated magnetite 
nanoparticles by hydroxylamine in aqueous environment (hydroxylamine-based 
method). The process provided star-shaped H-NPs with average diameter of ~63 
nm and metal content of 98.8% wt. gold and ~0.1% wt. iron. The extremely low 
amount of iron was though to result in poor MR imaging potentialities. In addition, 
the size of the nanoparticles exceeds the requirement for effective nanoparticle-
mediated radiosensitization70. Therefore, hydroxylamine-based method was 
discharged as potential synthesis method for the production of reliable theranostic 
nanoparticles, although star-shape hybrid nanoparticles might result suitable for 
other biomedical applications (e.g. magnetic sorting, biosensing). 
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The second synthesis process was based on a two-steps method based on the 
synthesis of oil-soluble hybrid nanoparticles by thermal decomposition of metal 
precursors and the further oil-to-water transfer of nanoparticles by Tween20 micelles 
(thermodecomposition-based method). Tween20 is a surfactant with polyethylene 
glycol hydrophilic moieties that was used in the past for the stabilization in water of 
hydrophilic nanoparticles for medical applications. Here, Tween20 was tested for the 
first time to stabilize hydrophobic hybrid nanoparticles. The process allowed the 
production of hydrophilic dumbbell-like H-NPs with average diameter of ~12 nm and 
65% wt. gold and 35% iron metal content. The chemical characterization confirmed 
thermodecompostion-based process provides good reproducibility over different 
synthesis batches and acceptable yield. Moreover, the resulting nanoparticles 
maintained colloidal stability in saline and protein solution at physiological conditions 
for a time interval typically required for medical applications (more than two days). 
The study of magnetic properties confirmed H-NPs, synthetized by 
thermodecomposition-based method, are in the superparamagnetic state with 
coercivity, magnetization saturation and T2-relaxivity values consistent with 
previously reported magnetite-based nanoparticles designed for medical 
applications. Therefore, Tween20-stabilized dumbbell-like H-NPs were identified as 
potential candidate for MRI-guided radiosensitization and then tested in human 4T-
MRI scanner and in vitro cell culture experiments.  
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The biological evaluations of H-NPs were conducted on human osteosarcoma 
MG63 and murine fibroblast 3T3 cell cultures. The results revealed that no 
cytotoxicity occurred in both cell cultures following exposure to H-NPs, even at high 
nanoparticle concentration (100 μg/ml). In particular, nanoparticles do not affect 
membrane integrity and morphology of cells and pinocytosis was proposed as the 
main uptake mechanism occurring in the internalization process of nanoparticle in 
cells. A clonogenic assay was conducted to study the radiosensitizing activity of H-
NPs through the quantification of the metabolic activity of cell cultures after exposure 
to nanoparticles and to 10 Gy megavoltage radiations. The results assessed that H-
NPs induce selective radiosensitization of osteosarcoma cells. In particular, 
irradiated osteosarcoma cells incubated with 10 μg/ml and 100 μg/ml H-NP-loaded 
media were respectively 20% and 28% less viable than irradiated cells without H-
NPs. On the other side, no synergic effect of radiations and nanoparticles was found 
in fibroblasts. Considering the fundamental role of fibroblasts in the recovery 
process following post-irradiation surgery, the evidence of osteosarcoma-specific 
radiosensitization provides a preliminary confirmation about the suitability of H-NPs 
for clinical implementation in osteosarcoma radiotherapy. Another confirmation 
arises from the evaluation of the theranostic potentialities of H-NPs. In particular, the 
analysis of the imaging performances of nanoparticles revealed that MR imaging 
provides reliable nanoparticle tracking in the range of concentrations effective of 
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radiosensitization. This evidence matches the basic requirement of theranostics, 
namely that the imaging window for the detection of the theranostic agent matches 
the concentration range with significant therapeutic efficacy.  
 
The experimental achievements addressed in this work provide innovative findings 
in the field of nano-theranostics based on gold-magnetite hybrid nanoparticles. A 
novel method for the production of blood-injectable Tween20-stabilized dumbbell-
like gold-magnetite hybrid nanoparticles with morphological, chemical and magnetic 
characteristics suitable for cancer targeting and MR imaging was set up. In 
particular, Tween20 was identified as a reliable alternative to more expensive 
capping agents for the water stabilization of hydrophobic hybrid nanoparticles89. 
Tween20-stabilized H-NPs were proposed as novel theranostic tools for MRI-guided 
radiosensitization of osteosarcoma cancer. In particular, H-NPs were proven to 
provide concentration-dependent osteosarcoma-specific radiosensitization in the 
concentration range suitable for MRI-tracking of nanoparticle distribution. However, 
our results are still preliminary and more studies are required to confirm the 
radiosensitization activity of H-NPs by convectional radiobiological assays and to 
investigate the mechanisms at the base of the osteosarcoma-specific 
radiosensitization. In addition, in vivo studies are strongly demanded to evaluate the 
capability of H-NPs to deliver theranostic radiosensitization in more realistic models. 
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Furthermore, the potentialities of H-NPs may be expanded in other cancer types. In 
fact, previous studies demonstrated that prostate, breast and cervical cancer cells 
respond well to gold nanoparticle radiosensitization, suggesting that H-NPs may 
provide theranostic radiosensitization in several cancer types. An extensive 
experimental campaign is therefore requested in order to identify new biological 
targets for potential H-NP implementation.  
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Appendix 
 
 
Study of the role of size and surface chemistry 
of gold nanoparticles on blood protein 
adsorption 
 
 
During the PhD activity, a preliminary study was conducted in order to investigate 
the role of size and surface chemistry of gold nanoparticles on the process of blood 
protein adsorption on the nanoparticle surface. The understanding of the influence of 
nanoparticle size and surface functionalization in the protein opsonozation is 
fundamental for the design of medical nanoparticles with favourable biological 
interactions in the blood tissue, as previously discussed in Chapter 1.2. In this work, 
we investigated the interactions between plasma proteins and gold nanoparticles 
(AuNP) developing ad hoc protocols to study the role of surface curvature and 
chemistry. AuNP with different size (10, 60 and 200 nm diameter) and surface 
chemistry (citrate and polyethylene glycol [PEG]) were analyzed. Citrate-coated 
AuNP are named 10 cAuNP, 60-cAuNP and 200-cAuNP depending on the size, 
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while PEG-coated nanoparticles are labelled as10-pAuNP, 60-pAuNP and 200-
pAuNP. PEG was selected as coating due to its anti-fouling properties.  
To emphasize the effect of curvature and surface reactivity of gold materials, we 
compared AuNP to gold macroscopic surface. Bare and PEGylated gold laminae 
were prepared and used as macroscopic control. 
The characterization of AuNP was performed through scanning electron microscopy 
(SEM) and dynamic light scattering (DLS), while laminae were characterized using 
X-ray photoelectron spectroscope (XPS). 
The effect of size and surface chemistry on the hydrodynamic radius of 
nanoparticles following incubation in human serum albumin and platelet-poor plama 
(PPP) solutions was evaluated by dynamic light scattering measurements. 
Different elution media, including sodium dodecyl sulfate (SDS), urea and sodium 
hydroxide in isopropyl alcohol (isopropyl alcohol:NaOH), were used to desorb 
proteins from AuNP and their elution efficacy was tested. 
Then, we focused on the comparison between protein adsorption on the different 
gold material following incubation with platelet-poor plasma to study the differences 
in composition of the protein corona at the equilibrium.  
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Material and methods 
Gold materials 
Citrate-coated gold nanoparticles (cAuNP) were purchased from TedPella (Redding, 
California). As reported by the manufacturer, a citrate shell surrounds nanoparticles 
to avoid aggregation by electrostatic repulsion. Thiolate-terminated PEG (3,500 Da, 
Sigma-Aldrich) was used to produce PEGylated gold nanoparticles (pAuNP) by 
incubating overnight cAuNP with solution containing a number of PEG moles 
equivalent to the moles of gold atoms on the surface of AuNP. 
AuNP were characterized by SEM imaging (FE-SEM Supra 40, Zeiss) using an 
InLens detector at 2–4 kV acceleration voltage. The hydrodynamic radius of AuNP 
was evaluated by DLS (Zetasizer 1000, Malvern). The planar gold samples 
consisted of gold films deposited on silicon substrate chips with a surface area of 1.5 
cm x1.0 cm. The chips were incubated for 10 min in piranha solution (1/3 hydrogen 
peroxide and 2/3 sulfuric acid), then immersed in boiling water and slowly cooled 
down to room temperature. Ethanol was used to wash quickly the surfaces, which 
were then treated by RF oxygen plasma (15 s at 200 W). After plasma treatment, 
bare surfaces were stored in ultrapure isopropyl alcohol, while PEGylated surfaces 
were incubated overnight with thiolated PEG solution (1 mM in ethanol 96 % vol.). 
Chemical surface characterization was performed using an ESCA200 instrument 
(Scienta-Gammadata ESCA200Uppsala Sweden).  
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Size of protein–AuNP complex 
The effects on size of AuNP after incubation with plasma proteins were studied 
using a protocol that involved incubation of nanoparticles with protein solutions, 
removal of unbound proteins and analysis of nanoparticle size distribution. 45 μg of 
AuNP were suspended in 1.5 ml protein solution, including PPP at physiological 
concentration and HSA (1.0 mg/ml), and incubated for 15 min at 37°C. The samples 
were then centrifuged 30 min at 8,950 g, resuspended in PBS buffer solution and 
washed twice (30 min at 8950 g). Size distributions of AuNP after protein adsorption 
were acquired using DLS.  
 
Protein desorption test 
Different media to desorb proteins from AuNP surface were tested: SDS 0.1 % w/v, 
8 M urea, and isopropyl alcohol:NaOH (2:3; isopropyl alcohol 99.5 %: 50 mM 
sodium hydroxide). PBS was used as negative control. Three replica for each type 
of eluting buffer were used. To remove residual unbound proteins from the 
suspension, four washing steps (30 min centrifugation at 10,000 g in PBS buffer 
solution) were applied. Then samples underwent the desorption process by 
incubation (1 h at 37°C) with 500 μl SDS (0.1 % w/v), 8 M urea, isopropyl 
alcohol:NaOH and PBS, respectively. After that, samples were washed (30 min 
centrifugation at 10,000 g), AuNP pellets were collected and supernatants were 
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lyophilized. Residual AuNP pellets and desorbed protein samples were suspended 
in sodium borate buffer (pH 9.3) and analyzed using a sensitive kit for protein 
quantification (CBQCA, Invitrogen). 
 
Protein adsorption profiles 
A specific protocol was developed to compare the protein adsorption profiles of the 
different gold materials (AuNP and laminae).  
The procedure included: (i) incubation of gold materials with PPP solution at 
physiological concentration; (ii) removal of unbound proteins; (iii) elution of proteins 
adsorbed on gold surfaces using SDS 1 % w/v and (iv) profile analysis of eluted 
proteins by 1D-electrophoresis. The experiment was performed normalizing the 
amount of gold material in each sample to the surface area of the laminae (1.5 cm2). 
Therefore, different amounts of nanoparticles were used depending on AuNP size: 
0.03 mg of 10-cAuNP and 10-pAuNP, 0.18 mg of 60-cAuNP and 60-pAuNP, 0.60 
mg of 200-cAuNP and 200-pAuNP. Nanoparticles were added to 1.5 ml PPP 
solution at physiological concentration. A tube without AuNP was used as negative 
control.  
Planar gold surfaces were placed in 24-wells TCP and incubated with 500 μl plasma 
solution. Samples were incubated 15 min at 37°C.  
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To separate unbound proteins from gold materials, two different methods were used 
for AuNP and planar surfaces, respectively.  
Four centrifugation steps (30 min at 18,000 g) were applied to AuNP samples.  
After washing procedure, the samples were incubated in 750 μl of SDS 1 % w/v for 1 
h at 37°C, then 700 μl supernatants were collected and stored at -20°C before 
electrophoretic analysis. 
The desorbed protein samples were suspended in LDS sample buffer with 1x 
reducing agent (Nu- PAGETM, Invitrogen) and loaded on acrylamide SDSPAGE gel 
(NUPage Novex 3-8 %, Tris–acetate). The gel was run at 150 V of constant voltage. 
After electrophoretic run, the gel was stained using a ProteoSilverTM Silver Staining 
Kit and digitalized by a GEL LOGIC 200 (Kodak) imaging system. 
 
Results 
SEM images of cAuNP (Fig. A1) showed a good matching between nominal size 
and measured diameter. The data acquired by DLS revealed a size increase of 
pAuNP with respect to cAuNP confirming the presence of polymer coating on 
pAuNP. The thickness of PEG coating was in the range from 5 to 10 nm.  
The XPS spectra of bare and PEGylated laminae are reported in Fig. A2. The data 
denoted a large difference in intensity between the peaks at 84 eV of bare and 
PEGylated surfaces. These peaks were referred to the concentration of metallic gold 
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on the outer surface of the samples. In correspondence to the decrease of the gold 
peak, two new components placed at 286 eV and 532 eV, correspondent to carbon 
and oxygen are found. These outcomes confirm the presence of PEG coating on 
planar surfaces. 
 
 
Figure A1. The rows are related to 10, 60 and 200 nm nanoparticles respectively. The left 
column report the SEM images acquired using cAu (100 nm bar). On the right, the size 
distributions related to citrate-coated and PEG-coated AuNP suspended in water are 
reported. 
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Figure A2. XPS analysis of bare (black line) and PEG-coated (gray line) gold laminae 
 
Size distribution trends before and after incubation with protein solutions (plasma 
and HSA) are reported in Fig. A3. It is possible to underline that a more consistent 
size increase was shown for nanoparticles incubated with plasma respect to AuNP 
incubated with HSA. In addition, the data suggested that PEG coating is more 
efficient than citrate in reducing the thickness of protein corona, especially for 60-
pAuNP. 
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Figure A3. Mean values of the peak related to non-clustered particles in size distributions 
acquired using DLS. The data are referred to cAuNP and pAuNP incubated in water 
(pristine), HSA solution (1.0 mg/ml) and platelet-poor plasma solution (physiological 
concentration), respectively 
 
Different methods have been tested to detach adsorbed proteins from AuNP 
surface, using SDS 0.1 % w/v, 8 M urea and isopropyl alcohol:NaOH (2:3; isopropyl 
alcohol 99.5 %: 50 mM NaOH). The results of protein desorption by the different 
media are presented in Fig. A4. Residual proteins attached to AuNP after the elution 
processes and proteins desorbed by different agents were quantified using a 
fluorescence assay. The analysis of fluorescence signals provided by AuNP protein 
corona after the elution process (Fig. A4.a) provided a ranking of the various 
desorption media, assuming that a higher fluorescence signal was related to a 
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thicker residual protein layer due to ineffective desorption. The different eluting 
media presented an increasing desorption efficacy starting from SDS 0.1 % w/v (14 
%) to 8 M urea (36 %) and isopropyl alcohol:NaOH (60 %) if normalized to positive 
control obtained by AuNP incubation with PBS. This trend was confirmed by direct 
quantification of the amount of desorbed proteins following elution, reported in Fig. 
A4.b. In this case, the more effective eluting media provided higher signal, since the 
amount of protein in the eluted solution depends on the efficacy of the desorption 
process.  
Although being the most efficacious among tested media for protein detachment, 
NaOH completely disrupts proteins, leading to the impossibility of recognizing the 
specific bands in the electrophoresis gels. Therefore, because 8 M urea may 
interfere with electrophoresis running, SDS was selected as eluting medium for the 
following protein adsorption studies. The surfactant concentration was increased to 
1 %w/v to improve desorption efficacy without affecting SDSPAGE analysis. 
The electrophoretic bands of proteins desorbed from plasma-incubated gold 
materials (AuNP and planar surfaces), having a normalized surface area of 1.5 cm2, 
are reported in Fig. A5. No remarkable differences between PEGylated and non-
PEGylated materials were observed. The comparison between planar surfaces and 
nanoparticles indicated that the bands related to laminae presented a slightly lower 
intensity with respect to AuNP bands. Moreover, 200 nm AuNP denoted a higher 
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protein adsorption if compared to 10 and 60 nm AuNP. The presence of a small 
fraction of heavy proteins (500 kDa ca.) was observed for AuNP samples, while no 
traces were revealed in the case of planar surfaces. 
 
 
Figure A4. The graph A provides the fluorescence signal of 10-cAuNP after incubation in 
HSA solution (5.0 mg/ml) and elution using different buffer solutions (PBS at physiological 
concentration, SDS 0.1 % w/w, 8 M urea, isopropyl alcohol:NaOH). The control is referred to 
the signal provided by only nanoparticles in ultrapure water. Graph B shows the mass of 
proteins desorbed through the different eluting processes 
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Figure A5. Electrophoretic gel stained by Silver staining. The labels of bands are listed and 
related to the samples as follows: 10-cAuNP (A), 10-pAuNP (B), 60-cAuNP (C), 200-cAuNP 
(D), 200-pAuNP (E), bare planar surface (F), PEGylated planar surface (G), negative control 
(H) 
 
Discussion 
 
Electrophoresis analysis confirmed the presence of heavy proteins on cAuNP 
protein corona, even if in a lower amount if compared to light proteins, which we 
consider responsible for nanoparticle stability in solution. This result was in 
accordance with previous studies102,103. When considering SDS-PAGE results, we 
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can generally observe that the bands related to planar surfaces are less intense with 
respect to the bands related to AuNP. The higher amount of proteins adsorbed to 
AuNP can be due to the higher AuNP surface reactivity. This, in turn, could be 
related to a higher protein binding strength, especially on citratecoated AuNP.  
The tendency of PEGylated AuNP to expose a thinner protein corona respect to 
citrate-coated AuNP can be related to PEG antifouling properties. DLS data about 
the size distribution of AuNP incubated with plasma and HSA confirming this 
hypothesis, in accordance with Walkey et al103. This result is in contrast with the 
evidence provided by electrophoresis, which showed similar band intensities for 
citrate-coated and PEGylated materials. This discordance could be explained 
assuming that the desorption procedure may have a different effect on PEGylated 
and non-PEGylated materials, due to a different action of surfactant molecules. It is, 
in fact, possible that SDS exerts a more effective detaching action on PEGcoated 
surfaces, which are specifically designed to minimize protein BE, respect to citrate-
coated and bare materials. This may induce an overestimation of proteins on PEG-
coated samples respect to non- PEGylated ones. 
One of the most critical point of the work consists in the high background signal in 
the NU-PAGE gel. Despite a great accuracy, the protocol was insufficient to reach a 
satisfactory signal-to-noise ratio to detect fine differences between the materials 
under investigation. The most probable reasons stand in the relatively small value of 
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surface area used for the tests or in the scarce removal efficacy of soluble unbound 
proteins. Differently from other literature studies103, in our experiments, the value of 
surface area available for protein adsorption experiments was specifically selected 
to allow the comparison between AuNP and planar surfaces. Therefore, the 
parameters used in the present study were optimized to permit the normalization of 
surface area values. A further increase in surface available for the adsorption tests 
would have led to the employ of an enormous amount of material. Beside the low 
signal-to-noise ratio obtained in the case of electrophoretic analysis, the use of a 
protocol involving protein detachment from AuNP is necessary to investigate protein 
adsorption on AuNP. The use of standard assays or direct methods for the precise 
quantification of adsorbed proteins based on the optical (and fluorescence) analyses 
is, in fact, inappropriate in the case of gold materials because it can generate 
artifacts related to the fluorescence quenching and unfolding effects induced in 
proteins by interaction with gold particles104. 
We showed that proteins desorption from AuNP is a critical point that needs to be 
considered. In fact, the most effective among protein desorption media tested in this 
study, isopropyl alcohol:NaOH solution, induced simply a partial protein desorption, 
in the order of 60 %. The other media tested (8 M urea and 
SDS 0.1 %w/v) achieved even lower desorption ratios (about 36 and 18 %). 
Additional care should be used in the choice of eluting media not interfering with the 
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following analysis. These issues should be carefully considered in the interpretation 
of past and future studies about protein adsorption to nanomaterials. 
In conclusion, we demonstrated the enhancement of surface reactivity from planar to 
nano-curved materials, showing how this affects complex phenomena like protein 
adsorption to the surfaces. 
A deep knowledge of biological effects of NP upon injection in the blood system is 
requested to develop safe and effective nanomaterials. This work represents a 
starting point for the understanding of complex interactions at the molecular level 
between blood and gold nanomaterials for medical applications. 
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